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ABSTRACT

DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF
AN INSTRUMENT TO ASSESS THE TREATMENT FIDELITY OF A
BRIEF OPPORTUNISTIC INTERVENTION TO REDUCE SUBSTANCE USE
AMONG PREGNANT WOMEN

By
Antonia Rae Torrey
August 2011

Dissertation supervised by Linda Goodfellow PhD, RN
Although abstinence from alcohol, tobacco, and other drugs (ATOD) among
pregnant women is a leading national objective, prenatal use has not decreased.
Evidence-based interventions that can be replicated in practice are critically needed and
brief interventions have shown promise in reducing prenatal ATOD use. The “I Am
Concerned” (IAC) brief opportunistic intervention is currently being implemented by
frontline primary prenatal care staff members in several areas of the United States.
Evaluation of treatment fidelity, to determine if behavioral interventions are delivered as
intended, is essential to controlled research. This study constituted the first step in the
development and psychometric evaluation of an instrument designed to measure the
treatment fidelity with which the IAC brief opportunistic intervention is implemented. A
conceptual framework derived from motivational interviewing and self-determination
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theory, both based on the fundamental assumption that individuals are inherently inclined
toward positive change, guided operationalization of the IAC behavioral elements that
ultimately took shape as the 18-item IAC treatment fidelity instrument.
This methodologic study used a 6-phase protocol to develop and refine the IAC
treatment fidelity instrument and evaluate its psychometric properties. Independent raters
used the instrument to evaluate audio recordings (N = 49) of experienced frontline staff
members implementing the IAC brief opportunistic intervention with standardized
patients portraying ATOD-using pregnant women in a simulated clinic setting.
Psychometric analysis provided evidence of content validity. Intra-class
correlation coefficients (ICC) calculated for inter-rater reliability were satisfactory for
subscales (0.64) and (0.62) and ranged from -0.07 to 0.81 for individual items. Internal
consistency alpha coefficients were satisfactory for the total scale (0.72) and lower than
acceptable for adherence (0.54) and competence (0.56) subscales. Overall high rater
percentage agreement and negatively skewed ratings distribution indicated that reliability
results were paradoxically low due to the base rate problem. The study results support
revision and ongoing testing of the IAC treatment fidelity instrument.
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Chapter I
Introduction
Statement of the Problem
Prenatal substance use is a foremost public health concern that transcends societal
boundaries (Chasnoff, Landress, & Barrett, 1990; Vega, Kolody, Hwang, & Noble,
1993), affecting not only the pregnant woman and her fetus, but her family and
community as well (Ettlinger, 2000; Reis, Mills-Thomas, Robinson, & Anderson, 1992;
Sun, 2004). Negative sequelae associated with prenatal use of alcohol, tobacco, or other
drugs (ATOD) have been well established (Armstrong et al., 2003; Bennett, 1999;
Mahony, 1998; Redding & Selleck, 1993; Shiono et al., 1995). Prenatal ATOD exposure
has been linked to significant fetal complications including prematurity (Shiono,
Klebanoff, & Rhoads, 1986), brain damage (Riley, McGee, & Sowell, 2004), and
intrauterine death (Mahony, 1998). Neurobehavioral teratogenic effects associated with
prenatal substance exposure include impaired executive function (Fried, 2002), lifelong
learning disabilities, and mental retardation (Streissguth et al., 1991).
Abstinence from alcohol, cigarettes, and illicit drugs among pregnant women are
leading maternal and infant health objectives that have been targeted in the agendas set
by Healthy People 2000, 2010 (Centers for Disease Control and Prevention, 2000).
Despite this national focus, prenatal use of these substances has not decreased (Substance
Abuse and Mental Health Services Administration, 2003, 2004, 2005, 2006, 2007, 2008,
2009, 2010).
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Background
Pregnancy has been described as a unique window of opportunity to positively
influence the substance-using woman (Daley, Argeriou, & McCarty, 1998). The regular
contact afforded by prenatal care allows providers an unparalleled chance to identify
pregnant women who are using potentially harmful substances. Current obstetric practice
guidelines recommend universal screening of pregnant women for past and present
ATOD use to facilitate timely recognition during the critical stages of fetal development
(American Academy of Pediatrics, 2002; American College of Obstetricians and
Gynecologists, 2008; American Society of Addiction Medicine, 1989). However,
prenatal care providers frequently fail to identify and intervene with substance-using
patients (Chasnoff, Neuman, Thornton, & Callaghan, 2001). Deficient knowledge
regarding treatment, lack of time, personal discomfort, and fear of acquiring a reputation
that would deter patients have all been reported as reasons why practitioners fail to screen
routinely for substance use by their pregnant patients (Zellman et al., 1999).
Societal attitudes toward pregnant women who drink alcohol, smoke cigarettes or
use drugs are negative, influenced by traditional beliefs about femininity and motherhood
(Carter, 2002). Society’s stigmatic, punitive view of prenatal substance use contributes to
the difficulties associated with the identification and treatment of this complex health
disorder (Reis et al., 1992). Pregnant women are reluctant to disclose ATOD use, fearing
negative responses such as distrust, labeling, disenfranchisement, incarceration,
prosecution, and loss of custody (Jessup, Humphreys, Brindis, & Lee, 2003; Selleck &
Redding, 1998; Tillett & Osborne, 2001). When prenatal ATOD use is identified, women
frequently deny the need for assistance to reduce their use (Howell & Chasnoff, 1999).
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Relatively few pregnant women accept referrals to substance use treatment and, among
those who do, less than half follow through with the full course of treatment (Brady &
Ashley, 2005).
There is a critical need for effective interventions that can be promptly
implemented in the primary prenatal care setting when a pregnant woman discloses
potentially harmful substance use to a healthcare provider. Brief interventions are timelimited, patient-focused, counseling strategies, implemented with the goal of motivating
healthy decision-making, that have shown promise in the treatment of problem behaviors
(Clay, 2010). Brief interventions are not only used for patients actively seeking treatment,
but can occur opportunistically when health care providers become aware of problem
behaviors during encounters that were initiated by patients for another reason (Moyer,
Finney, Swearingen, & Vergun, 2002). Brief drinking-focused interventions have been
used effectively during clinical encounters between health care providers and patients to
motivate change (Bien, Miller, & Tonigan, 1993; Emmen, Schippers, Bleijenberg, &
Wollersheim, 2004). Researchers have also reported success using this methodology in
decreasing substance use during pregnancy (Armstrong et al., 2003; Chang et al., 2005;
Ferreira-Borges, 2005; O'Connor & Whaley, 2007). Despite the reported success of these
and similar studies, they lack key methodological ingredients that are critically needed to
facilitate effective translation of a promising brief intervention from the research setting
to the practice arena.
Before a behavioral therapy can be generalized to clinical practice, it must
meet the standards required of an empirically supported therapy by incorporating and
reporting methodological aspects that make it reasonable to assume that the positive

3

effects observed were actually a result of the experimental treatment rather than from
other confounding factors (Carroll & Rounsaville, 2007; Chambless & Hollon, 1998).
This can be illustrated by comparing behavior therapy research to a controlled clinical
trial conducted to investigate the effectiveness of a new drug. In addition to all of the
procedural elements required of any randomized, controlled clinical trial, a drug clinical
trial must stipulate specifics regarding the drug’s pharmacokinetics and the precise
dosages used in the study. This same rigor is required of a clinical trial seeking to
determine the efficacy of a behavioral intervention. The study must incorporate and
provide precise information about the components of the treatment intervention that
distinguishes it from other behavioral interventions, and provide methodological
assurance that the treatment intervention was actually delivered.
Monitoring and evaluating treatment fidelity, to determine if the intervention was
delivered as intended, is an essential requirement of controlled therapeutic intervention
research (Bellg et al., 2004). This imperative has become progressively evident as the
literature increasingly abounds with reports of efficacious behavioral therapies that fail to
be put into practice (Carroll & Rounsaville, 2007).
Brief intervention implementation is a flexible, dynamic, individualized event,
and these factors must be considered when designing fidelity assessment strategies.
Measurement of treatment fidelity requires use of a research instrument that indexes the
essential elements of an intervention and quantifies interventionist behaviors (Stein,
Sargent, & Rafaels, 2007). Development of a treatment fidelity instrument entails
operationalization of the treatment concepts and clinical protocol, guided by the theory
on which the brief intervention is founded (C. F. Waltz, Strickland, & Lenz, 2005).
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There are further considerations to be taken into account in the potential
extrapolation of an efficacious intervention to the clinical practice setting. Most brief
intervention studies that have been published to date have used specialists, such as
physicians or therapists, in the role of interventionist. While such a design undoubtedly
optimizes internal validity, it limits applicability to the real world of managed primary
care where cost issues are a paramount consideration, and specialist time is a rare and
expensive commodity ("Rising Costs Force," 2004; Wallace & Savitz, 2008). Primary
care personnel with the earliest and most sustained contact with patients are frontline
staff (Grumbach, Osmond, Vranizan, Jaffe, & Bindman, 1998). Frontline caregivers
found in primary care offices or clinics are usually registered nurses, licensed vocational
nurses, licensed practical nurses, and medical assistants (Chasnoff, McGourty, Wells, &
McCurties, 2008; Grumbach & Bodenheimer, 2004). If potentially harmful substance use
is disclosed to the caregiver, the apposite response is a brief opportunistic intervention
(Chang, 2004), If potentially harmful substance use is disclosed to the caregiver, the
apposite response is a brief opportunistic intervention
Prenatal care providers in several areas of the United States (Alabama, Arkansas,
California, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, New Jersey, New Mexico,
Nevada, Oklahoma, Oregon, West Virginia, and the Commonwealth of Puerto Rico) use
frontline staff to implement a particular brief opportunistic intervention for pregnant
women who disclose current ATOD use (Chasnoff et al., 2008; Children's Research
Triangle, 2008). This is the “I Am Concerned” (IAC) brief opportunistic intervention,
which was specifically developed to address harmful prenatal substance use (Chasnoff &
McGourty, 2003).

5

Awareness of IAC implementation by frontline staff, coupled with a lack of
research demonstrating large-scale success with brief interventions in reducing ATOD
use in pregnancy stimulated this proposal, which was born out of a desire to determine
the efficacy of the IAC brief intervention when implemented by frontline staff. This study
is the first step toward realizing this goal. There is a critical need for controlled clinical
research that incorporates rigorous assessment of treatment fidelity to foster identification
of evidence-based, efficacious interventions that help to reduce prenatal substance use.
Such studies are necessary to promote effective translation from the research setting to
primary care practice where the treatment can benefit childbearing women, their families,
and society.
Purpose of the Study
The specific aims of this study were to: (a) develop an instrument that can be used
accurately and reliably to measure the treatment fidelity with which the IAC brief
opportunistic intervention is implemented; and (b) establish evidence of validity and
reliability associated with the use of this instrument.
The long-term goals of this line of research are to: (a) use this instrument to
measure and ascertain the treatment fidelity with which frontline staff implement the IAC
brief opportunistic intervention when it is delivered in a clinical setting for pregnant
women who disclose ATOD use, (b) determine the efficacy of the IAC brief
opportunistic intervention when implemented by frontline staff through randomized
controlled study, and (c) disseminate the findings derived from this research to foster use
of evidence-based interventions and reduce maternal ATOD use and adverse fetal
consequences.
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Research Questions
This dissertation project answered the following questions:
1. What is the content validity associated with an instrument developed to assess
treatment fidelity in the delivery of a brief opportunistic intervention to
decrease the use of alcohol, tobacco, and other drugs by pregnant women?
2. What is the inter-rater reliability associated with use of an instrument
developed to assess treatment fidelity in the delivery of a brief opportunistic
intervention to decrease the use of alcohol, tobacco and other drugs by
pregnant women?
3. What is the internal consistency reliability associated with use of an
instrument developed to assess treatment fidelity in the delivery of a brief
opportunistic intervention to decrease the use of alcohol, tobacco, and other
drugs by pregnant women?
Operational Definitions of Study Terms
Frontline staff members. These are primary health care personnel who interact
with patients in advance of physicians or mid-level practitioners. The frontline staff
members who work in prenatal offices or clinics are usually registered nurses, licensed
vocational nurses, or medical assistants.
Brief opportunistic intervention. A short, structured, behavioral treatment
implemented by prenatal care providers when a clinical opportunity is presented to
facilitate healthy decision-making on behalf of clients who are not specifically seeking
treatment to reduce their ATOD use.
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Treatment fidelity. This is the degree to which the IAC brief opportunistic
intervention is delivered as intended by the treatment protocol. The components of
treatment fidelity are: (a) adherence, the extent to which the essential elements that
distinguish the IAC brief opportunistic intervention have been implemented; and (b)
competence, the quality of implementation and the skill with which frontline staff deliver
the intervention and exhibit behaviors likely to engage and motivate clients.
Prenatal substance use. Denotes any use of alcohol, tobacco, or illicit drugs, or
misuse of prescription drugs during pregnancy.
Standardized patient. Individual recruited and trained to act as a real patient to
simulate a set of symptoms or problems. In this study, associate degree nursing students
were the standardized patients. They portrayed ATOD-using pregnant women in a
simulated clinical environment.
Assumptions Underlying the Research
This study rested on the following assumptions:
1. Psychological traits and behaviors can be quantified and measured.
2. It is possible to measure treatment fidelity in a simulated clinical situation.
3. Independent raters listening to audio recordings of treatment sessions will be
able to determine quantitative, objective measurements of treatment fidelity.
Significance to Nursing
Despite additional funding designated for the treatment of drug-addicted,
childbearing women, little progress has been achieved with the national initiatives that
have been implemented to discourage prenatal substance use (Substance Abuse and
Mental Health Services Administration, 2008). National objectives regarding prenatal
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substance exposure remain unrealized as abstinence rates associated with alcohol and
other drugs have declined or remained the same (National Center for Health Statistics,
1999). There is significant need for research to identify interventions that will decrease
rates of ATOD use among childbearing women. This research endeavor was an initial
step in addressing this need.
Nursing researchers seek to provide evidence that supports the use of particular
practices that are effective and efficient (Polit & Hungler, 1999). This study was
premised on the staffing mix found in the primary health care environment and the reality
of spiraling health care costs. Frontline staff members are cost-effective caregivers and,
as such, they interface first and most frequently with patients. Prenatal care providers are
using frontline prenatal clinic staff to implement the IAC brief opportunistic intervention
for pregnant women who disclose current ATOD use (Chasnoff, Wells, McGourty, &
Bailey, 2007). However, the quality of brief intervention implementation by this level of
provider has yet to be determined. This study was a necessary first step toward
determining the treatment fidelity with which frontline staff members implement brief
opportunistic interventions in the primary clinic setting. In addition, the findings of this
study will lay the foundation for a future randomized, controlled study measuring the
efficacy of the IAC brief opportunistic intervention.
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Chapter 2
Review of Literature
The continuing phenomenon of potentially harmful ATOD use during pregnancy
has driven the quest for effective treatments (American College of Obstetricians and
Gynecologists Committee on Ethics, 2004). Brief interventions using motivational
interviewing techniques have shown promise in reducing prenatal substance use
(Armstrong et al., 2003; Ferreira-Borges, 2005; Haug, Svikis, & DiClemente, 2004;
O'Connor & Whaley, 2007). However, meaningful, replicable findings from randomized
clinical trials exploring the efficacy of brief interventions are dependent on faithful
delivery of the independent variable. A valid and reliable instrument enabling assessment
and quantification of interventionist behaviors is necessary to establish treatment fidelity.
The literature review for this research was organized around these elements and includes
a summary of the research findings related to the harmful effects of prenatal ATOD
exposure, brief intervention study findings and a comprehensive examination of the
literature associated with treatment fidelity. I begin by describing the conceptual
framework that provided the theoretical context for this study.
Conceptual Framework
This study was guided by concepts derived from motivational interviewing (MI),
first described in 1983 when psychologist William R. Miller published an article
explicating the innovative process he used to intervene with problem drinking. In the
ensuing years, the concepts and approaches fundamental to MI have been further refined,
elaborated and articulated (Miller & Rollnick, 1991, 2002), and MI’s theoretical
framework has evolved through substantial testing (Miller & Rollnick, 2009).
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Motivational interviewing. MI grew out of dissatisfaction with the
confrontational, aggressive strategies that were widely advocated at the time for the
treatment of addictive behaviors (Miller & Rollnick, 1991). Defined as a “client-centered,
directive method for enhancing intrinsic motivation to change by exploring and resolving
ambivalence” (Miller & Rollnick, 2002, p. 25), MI draws on constructs from several
theoretical frameworks. The emphasis placed by client-centered theory on empathy as a
critical condition of a therapeutic atmosphere (C. R. Rogers, 1956) was credited as
providing significant inspiration during the development of MI. Maintaining a structured
and directive therapeutic interaction within a collaborative environment is a hallmark of
cognitive therapy (Beck, Wright, Newman, & Liese, 1993) that also became a central
element of MI. Other theories that influenced the development of MI include cognitive
dissonance theory (Festinger & Carlsmith, 1959), which posits that people are driven to
reduce inner conflict created by discrepancies between their actions and their beliefs, and
the theory of self-perception (Bem, 1967), which holds that people tend to develop
attitudes by observing their behaviors, rather than the reverse.
Miller and Rollnick (1991) aligned MI with key constructs of the trans-theoretical
model of change (Prochaska & DiClemente, 1982). This model includes the hypothesis
that individuals who are modifying behaviors move from a state of pre-contemplation,
when no change is being considered, into a cyclical, multi-stage process that progresses
through contemplation, determination, action, maintenance, and relapse. Prochaska and
DiClemente’s inclusion of relapse as a normal, nonpathologic stage in the process of
change was significant because it acknowledged that individuals often return to previous
behaviors when attempting to change long-standing patterns. The original trans-
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theoretical model was conceptualized as a wheel of change, around which individuals
typically circled several times before achieving stable behavior change (Prochaska &
DiClemente, 1982), later revised to a spiral model, reflecting research findings that
relapsing individuals typically reinitiate the process of change in the contemplation or
preparation stages instead of regressing all the way back to the pre-contemplation stage
(Prochaska, DiClemente, & Norcross, 1992). Initially, MI theory included a hypothesis
that motivational approaches should differ in accordance with the location of the client in
the change process, and specific therapeutic tasks targeted to each of the trans-theoretical
stages were originally recommended to facilitate client progress toward sustained change.
(Miller & Rollnick, 1991). However, this hypothesis was not supported by the findings of
Project MATCH, a large clinical trial conducted to determine if patient-treatment
matching improved outcomes for alcohol dependent individuals (Project MATCH
Research Group, 1998).
Principles of motivational interviewing. W. R. Miller and Rollnick (2002)
identified four general principles involved in the application of MI. These are: expressing
empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy.
Empathy is defined as “the quality or process of entering fully, through
imagination, into another’s feelings or motives” (Barnhart & Barnhart, 1984, p. 691). An
empathetic counseling approach is not unique to MI, because many forms of Rogerian
client-centered psychotherapy involve empathy on the part of the therapist to some
degree. However, MI places particular emphasis on empathy, which is described as a
“fundamental and defining characteristic” (Miller & Rollnick, 2002, p. 37). Expressing
empathy involves perceiving the world from the perspective of the client through
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respectful, reflective listening (Miller & Rollnick, 1991, 2002). The therapeutic attitude
that frames this principle is one of acceptance, a mind-set that denotes understanding
rather than agreement or endorsement. This attitude of respect and acceptance is believed
essential to the creation of a therapeutic alliance that will foster change. Observer ratings
of therapist empathy were found to be predictive of positive therapeutic outcomes in a
study conducted by W. R. Miller, Taylor, and West (1980) with problem drinkers, as well
as in a large meta-analysis of empathy research (Bohart, Elliott, Greenberg, & Watson,
2002). Another crucial aspect of this principle is recognition that client ambivalence is a
normal component of change, and is to be expected rather than viewed as aberrant.
The second principle of MI is intentional development of discrepancy, predicated
on the hypothesis that people are motivated to change when they perceive inconsistencies
between their behaviors and their core values (Miller & Rollnick, 1991, 2002). This
directive approach is a departure from traditional client-centered counseling, which is
non-directive and exploratory (C. R. Rogers, Kirschenbaum, & Henderson, 1989). MI
involves facilitating clients’ awareness of the discrepancy between the way they want
their life to be versus their current behavior through the use of techniques such as openended questions, that elicit change talk (self-motivating speech) (Miller & Rollnick,
2002). The therapist attempts to amplify the perception of discrepancy by reflecting,
elaborating, and affirming the client’s change talk. A significant correlation was
established between the frequency and strength of commitment language voiced by drugusing clients during the final moments of MI therapy and their degree of abstinence at a
1-year follow-up (Amrhein, Miller, Yahne, Palmer, & Fulcher, 2003). The therapeutic
goal is to help the client develop awareness of discrepancy without feeling pressured or
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coerced to do so. In keeping with this goal, a fundamental dynamic involved in
developing discrepancy is that it is the client, not the therapist, who articulates the
reasons for change. This accords with the finding that motivation tends to be enhanced
when people hear themselves presenting arguments in support of change, as opposed to
hearing them voiced by another (Bem, 1967). Although the mechanism by which MI
triggers behavior change is unclear, the occurrence of increased commitment language
may evidence a pivotal decision to engage in the process of change (Miller & Rose,
2009).
Because MI-guided therapists expect clients to be ambivalent regarding the
importance of change, it follows that client reluctance to change will also be viewed as a
normal, non-pathological part of the change process. This philosophy is manifested in the
third general MI principle, rolling with resistance (Miller & Rollnick, 1991, 2002). Client
resistance is not only expected, it is conceptualized as a treatment opportunity that can
facilitate meaningful movement in the direction of change. Any resistance on the part of
the client is met with therapist nonresistance, and argument is assiduously avoided.
Clients’ feelings are respected and acknowledged through reflective responses, and
resistant comments are viewed as an indication to respond differently or alter the
approach. MI places clients, rather than therapists, in the role of the expert who must find
solutions to the problems they have identified. In keeping with this overriding
philosophy, client questions are typically reframed and directed back to the client. A
controlled comparison conducted with problem drinkers found a directive-confrontational
counseling approach significantly predictive of increased frequency of client resistant
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responses during therapy and their reported level of alcohol consumed at the 12-month
follow-up (Miller, Benefield, & Tonigan, 1993).
The fourth theoretical premise upon which MI is based is the concept of selfefficacy (Miller & Rollnick, 1991, 2002). Self-efficacy, defined as an appraisal of one’s
ability to carry out a specific task (Bandura, 2007), is a key predictor of an individual’s
degree of perseverance (Bandura, 1977). Support of client self-efficacy flows logically
from previous MI principles; the assertion that the client has the sole responsibility to
direct change implies that the client is perceived as capable of doing so (Miller &
Rollnick, 1991, 2002). An intrinsic aspect of this principle is recognition that the
therapist’s own belief in the client’s ability to accomplish meaningful change can work as
a “self-fulfilling prophecy” (Miller & Rollnick, 2002, p. 41). The outcomes of individuals
receiving treatment for alcoholism were significantly influenced in the direction of
therapists’ expectancies (Leake & King, 1977; Parker, Winstead, & Willi, 1979). Viewed
from an MI perspective, enhancing confidence is an attribute that is elicited, rather than
imposed by the therapist, through interviewing techniques that include reframing,
affirming previous successes, brainstorming, and providing information when appropriate
within the context of the therapeutic interaction (Miller & Rollnick, 2002).
Spirit of motivational interviewing. Miller and Rollnick (2002) emphasized that
MI is more of “a way of being with people” (p. 34) than a set of techniques and cautioned
that effective application of MI requires thoroughly understanding the spirit of MI. The
components of the fundamental spirit of MI are (a) creating a collaborative and
supportive atmosphere; (b) evoking motivation for change from within the client; and (c)
affirming and respecting the client’s autonomy. Collectively, these overarching
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characteristics generate the fundamental nature that appropriately occurs within the
context of MI-guided therapy.
The FRAMES model. Various modified approaches have been developed that
integrate the spirit and principles of MI with non-motivational interviewing techniques
(Miller & Rollnick, 2002); these have been termed “adaptations of motivational
interviewing” (AMI) (Burke, Arkowitz, & Menchola, 2003). Most studies testing the
efficacy of MI have been found to involve AMIs (Burke et al.), rather than the pure
clinical style described by Miller and Rollnick (1991, 2002). One such AMI is the
FRAMES model, a brief intervention approach that has been widely adopted as a strategy
to stimulate and support client behavior change (Miller & Rollnick, 1991). FRAMES
provided inspiration to the authors of the IAC brief opportunistic intervention (Chasnoff
& McGourty, 2003) that is at the core of this study. The acronym “FRAMES” represents
the key elements embodied with this approach:
1. Feedback is provided regarding the interventionist’s appraisal of the client’s
current health status.
2. Responsibility of the client for behavior change is explicitly emphasized.
3. Advice is given unambiguously to make a change.
4. Menu of strategies is provided that can assist the client to achieve change.
5. Empathy forms the foundation of the interventionist’s interaction with the
client.
6.

Self-efficacy is fostered and reinforced by the interventionist.

Numerous clinical trials have investigated the effectiveness of MI techniques in
the treatment of addictive behaviors, and several meta-analyses have been carried out to
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determine effect sizes across studies (Burke et al., 2003; Carey, Scott-Sheldon, Carey, &
DeMartini, 2007; Hettema, Steele, & Miller, 2005; Rubak, Sandbaek, Lauritzen, &
Christensen, 2005; Vasilaki, Hosier, & Cox, 2006). While MI counseling strategies were
effective in the treatment of alcohol abuse (Burke et al., 2003; Carey et al., 2007;
Hettema et al., 2005; Rubak et al., 2005; Vasilaki et al., 2006), and drug use (Burke et al.,
2003; Hettema et al., 2005), they did not result in significant reductions in smoking
(Burke et al., 2003; Hettema et al., 2005; Rubak et al., 2005). MI was associated with
larger effect sizes earlier in the course of addiction counseling in comparison with control
or no treatment, which decreased over time as control group effect sizes effectively
caught up with MI treatment groups (Hettema et al., 2005; Vasilaki et al., 2006). The
positive effects of MI were more enduring when combined with other therapies and when
introduced early in the treatment regimen (Hettema et al., 2005). MI was found to be
more effective for both treatment-seeking and nontreatment-seeking individuals, although
larger effect sizes were noted with treatment-seeking samples (Vasilaki et al., 2006).
Motivational interviewing theory. Although substantial evidence exists to support
the efficacy of MI-guided therapy, it has been criticized for lacking a sound theoretical
base (Draycott & Dabbs, 1998). Self-determination theory (SDT), a conceptual model of
motivation proposed by Deci and Ryan (2002), has been suggested as a useful framework
with which to illuminate the basic theoretic assumptions that undergird MI (Foote et al.,
1999; Ginsburg, Mann, Rotgers, & Weekes, 2002; Markland, Ryan, Tobin, & Rollnick,
2005; Vansteenkiste & Sheldon, 2006).
Self-determination theory. SDT evolved from the study of intrinsic and extrinsic
motivation; and describes the nature of human needs, the motives that drive need
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fulfillment, and the environmental characteristics that affect human behavior (Deci &
Ryan, 2002; Ryan & Deci, 2006). A basic tenet of SDT is the supposition that human
beings have an instinctive inclination to develop an integrated self-image (Deci & Ryan,
2002). This propensity to develop an inner sense of unity fosters the drive to establish
constructive links among various facets of one’s own psyche as well as establish
meaningful connections with other individuals.
According to SDT, individuals have fundamental needs that must be satisfied to
achieve psychological health (Deci & Ryan, 2000, 2002; Ryan & Deci, 2000). Needs are
conceptualized as “innate psychological nutriments that are essential for ongoing
psychological growth, integrity, and well-being” (Deci & Ryan, 2000, p. 229). The drive
to meet these needs causes individuals to consciously or unconsciously seek situations
that will allow them to be fulfilled (Deci & Ryan, 2002). Three universal needs are
identified, the needs for autonomy, competence, and relatedness.
1. Autonomous individuals perceive that their behavior is self-determined, rather
than controlled by external forces.
2. Individuals who have fulfilled their need for competence have a sense of
confidence and effectiveness in relation to their interactions with their social
environment and the expression of their capabilities.
3. Satisfying the need for relatedness instills feelings of connectedness,
belonging and genuine caring with others.
Another fundamental concept of SDT is the distinction between causal variables
that motivate an individual’s behaviors. SDT differentiates between behavior that is
motivated autonomously and behavior motivated by a controlled orientation (Deci &
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Ryan, 2002; Ryan & Connell, 1989). Behavior motivated by autonomous orientation
occurs with volition from an internal impetus and is based one’s own interests.
Conversely, controlled orientation refers to behavior that involves external regulation,
such as through coercion from others, or self-edicts about how one should behave. These
motivations are conceptualized as ordered along a “gradient of autonomy” (Ryan &
Connell, 1989, p. 759) from internal to external causality. SDT theory includes the
hypothesis that individuals will tend to gravitate toward autonomously motivated
behaviors when their innate needs for competence, relatedness, and autonomy have been
met (Deci & Ryan, 2002; Ryan & Connell, 1989).
According to SDT, individuals are intrinsically motivated to self-regulate and
become increasingly autonomous through a process called internalization. (Deci & Ryan,
2002; Ryan & Connell, 1989). Internalization involves the assimilation of externally
regulated values into internally regulated values. Two forms of internalization are
recognized by SDT, introjection and integration. Introjection is a suboptimal type of
internalization that occurs when an externally regulated value is partially taken in without
full acceptance as one’s own. Integration involves more extensive internalization that
takes place when individuals fully assimilate an externally regulated value, synthesizing
the behavior with their core sense of self and accepting it as their own.
Motivational interviewing and self-determination theory. The basic premises
of SDT mesh conceptually with the elements that shape MI and provide a theoretical
basis for interpreting the efficacy of MI (Foote et al., 1999; Ginsburg et al., 2002;
Markland et al., 2005; Vansteenkiste & Sheldon, 2006). Both frameworks are based on
the fundamental assumption that individuals are inherently inclined toward positive
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change (Markland et al.; Vansteenkiste & Sheldon). Described by Deci and Ryan (2002)
as “natural, innate, and constructive tendencies to develop an ever more elaborated and
unified sense of self” (p. 5), this concept was characterized by Miller and Rollnick (2002)
as “a natural process of change” (p. 4). These beliefs support the approach to counseling
that is endorsed by both SDT and MI, that the therapist’s role is to elicit the client’s
inherent motivation, rather than attempt to establish a process of change. STD defines
this concept as assisting “autonomous motivation for specific health care or educational
behaviors” (p. 239).
Markland and colleagues (2005) aligned the construct of universal needs specified
within the SDT framework to MI principles and techniques, and, although not explicitly
stated, the FRAMES strategies of giving advice and providing feedback. The MI-guided
interventionist supports clients in meeting each of the SDT basic needs as follows:
1. Competence: present clear and neutral information about behavior and
outcomes, help the client develop appropriate goals, provide positive
feedback, and support self-efficacy.
2. Autonomy: avoid coercion, roll with resistance, explore options, encourage
change talk, and let the client make decisions about what and how to change.
3. Relatedness: express empathy, explore client’s concerns, demonstrate
understanding of the client's position, and avoid judgment or blame (p. 821).
Seen through the conceptual lens of SDT, MI therapeutic outcomes can be
construed as associated with fulfillment of basic needs (Markland et al., 2005;
Vansteenkiste & Sheldon, 2006). Placing key MI elements within the conceptual

20

boundaries of SDT creates a theoretic bridge between MI and behavior change and
affords researchers a means of gaining deeper insight into the way that MI works.
Summary. The focus of this study was development of a research instrument
capable of valid and reliable measurement of the fidelity with which the IAC brief
opportunistic intervention is implemented. This process required operationalization of
complex variables, reducing them from abstract concepts to observable indicators. The
likelihood that the resulting tool reflected the phenomenon of interest was enhanced
through the use of a guiding conceptual framework (C. F. Waltz et al., 2005). MI
principles and techniques, instrumental in the development of the IAC, are theoretically
strengthened when bolstered by SDT constructs. The union of these two models provided
a core ideology that was used to guide the conceptual translation of key principles
involved in IAC implementation.
Prenatal Substance Exposure
Alcohol, tobacco, marijuana, cocaine, opioids, and amphetamines are the drugs
most commonly used by pregnant women (Shiono, 1996; Suellentrop, Morrow, Williams,
& D'Angelo, 2006; Vega et al., 1993) and poly-drug use patterns are pervasive (Chasnoff
et al., 2008; Lester, Andreozzi, & Appiah, 2004; Lester et al., 2001; Wolfe, Davis,
Guydish, & Delucchi, 2005). Although public concern has been primarily focused on
illicit substances, use of legally obtained alcohol and tobacco is far more prevalent during
pregnancy. Researchers conducting a landmark prenatal substance exposure study in
1992, analyzed data obtained through urine toxicology screening and self-reported
tobacco use from 29,494 pregnant women presenting for delivery in California hospitals
(Vega et al.). Specific drug prevalence rates were: tobacco, 8.82%; alcohol, 6.72%;
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marijuana, 1.88%; opioids, 1.47%; cocaine, 1.11%; amphetamines, 0.66%. Overall,
5.16% of the women screens were positive for one or more illicit drugs. The
predominance of alcohol and tobacco use is corroborated by national prevalence data
from the National Household Survey on Drug Abuse (Substance Abuse and Mental
Health Services Administration, 2010). Estimated rates of use from the 2009 survey (the
most recent year available for study) of pregnant women aged 15 to 44 years were:
tobacco, 15.3%; alcohol, 10.0%; and illicit drug use, 4.5% (individual illicit drug
prevalence rates were not provided).
Prenatal alcohol use. Alcohol is a widely recognized human teratogen and the
negative effect on fetuses of mothers who consume alcohol has been well established.
Fetal alcohol exposure is a principal cause of birth defects, mental retardation, and
neurodevelopmental disorders, sequelae that are entirely preventable (Barr & Streissguth,
2001; Goodlett, Horn, & Zhou, 2005; Lester, Tronick et al., 2004; Meschke, Holl, &
Messelt, 2003). During pregnancy, there is no amount of alcohol that can be safely
consumed, nor any period of time that is considered safe to drink (Barr & Streissguth,
2001). Alcohol crosses the placental barrier and enters fetal circulation rapidly after
maternal ingestion (Streissguth & Finnegan, 1996). Analysis of the placental transfer
properties of alcohol reveals that it diffuses freely across the placental membrane,
resulting in fetal serum concentrations that equal or exceed maternal serum levels (Little
& VanBeveren, 1996). Alcohol is eliminated more slowly from amniotic fluid than from
maternal circulation, remaining in fetal circulation when it is no longer present in
maternal serum (Tranmer, 1985).
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Prenatal tobacco use. There is considerable evidence regarding the fetal harm
caused by prenatal exposure to tobacco, adverse impacts that extend into the postnatal
period. Although there has been a concerted effort to increase awareness regarding the
risks associated with smoking during pregnancy, prenatal tobacco use remains a
significant public health concern (Centers for Disease Control and Prevention, 2000).
Cigarette smoke is a complex substance composed of more than 4,000 compounds; some
originate in the tobacco itself and others are created when the tobacco is burned (Lester,
Andreozzi et al., 2004; Talbot, 2008). Harmful effects associated with intrauterine
tobacco exposure are thought to be primarily due to chemically mediated interference
with reproductive organ function and the teratogenic aspects of nicotine (Greene &
Goodman, 2003; Lester, Andreozzi et al.; Medoff-Cooper & Verklan, 1992; Miles,
Lanni, Jansson, & Svikis, 2006)
Prenatal opiod use. Opioid describes any drug that attaches to opiate receptors in
the central nervous system (Deglin & Vallerand, 2009). This class of drugs includes
morphine (a naturally occurring opioid), heroin (semi-synthetic), and methadone
(synthetic); all of these produce nearly identical effects (U.S. Drug Enforcement
Administration, 2009). A rapid rate of opioid placental transfer has been demonstrated
directly using animal models (Ruckebusch, Gaujoux, & Eghbali, 1976) and indirectly by
acute signs of withdrawal exhibited by opioid-exposed neonates following delivery
(Greene & Goodman, 2003). Neonatal abstinence syndrome is marked by behavioral and
physiologic indicators that include irritability, hypertonia, diarrhea, vomiting, and poor
feeding (Curet & Hsi, 2002; Johnson, 2001; Kenner, Dreyer, & Amlung, 2000; Oei &
Lui, 2007).
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Prenatal cocaine use. Cocaine’s vasoconstrictive properties have been suggested
as the mechanism underlying the damage associated with prenatal use (Holzman &
Paneth, 1994; Plessinger & Woods, 1993, 1998). Uterine arterial vasoconstriction
induced by maternal cocaine use is associated with impaired placental perfusion and
subsequent fetal hypoxemia (Woods, Plessinger, & Clark, 1987). An in vitro placental
perfusion study found that cocaine interfered with amino acid transport across the
placenta, a phenomenon that may further contribute to the fetal harm associated with
prenatal use of cocaine (Pastrakuljic, Derewlany, Knie, & Koren, 2000).
Prenatal amphetamine use. Amphetamine mixtures comprise a group of central
nervous stimulants, including amphetamine, methamphetamine, and dextroamphetamine,
with very similar properties and actions (National Institute on Drug Abuse, 2009). These
drugs induce synaptic release of catecholamines, producing numerous pharmacological
effects that include vasoconstriction, insomnia, and anorexia (Deglin & Vallerand, 2009).
The maternal and fetal effects of amphetamine, while similar to those produced by
cocaine, are not identical (Plessinger, 1998). Animal research has demonstrated the
facility with which amphetamine compounds cross into the fetal compartment, resulting
in peak fetal concentrations that ultimately exceed maternal serum levels due to the
slower rate of fetal elimination (Burchfield, Lucas, Abrams, Miller, & DeVane, 1991).
Fetal damage associated with prenatal amphetamine exposure may occur directly through
placental transfer or indirectly as a result of vasoconstrictive and sympathomimetic
effects on the mother (Wouldes, LaGasse, Sheridan, & Lester, 2004). Neonatal
abstinence syndrome that has been observed by some researchers studying amphetamine-
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exposed newborns (Oei & Lui, 2007; Smith et al., 2003) has not been observed in others
(Ludlow, Evans, & Hulse, 2004).
Brief Interventions
Brief intervention has been characterized as a short, dynamic form of
psychotherapy (Borden, 1999) delivered by trained individuals with the goal of assisting
clients with problems of living (Gurman & Messer, 2005). Brief intervention is a type of
treatment modality that refers to multiple therapeutic techniques of varying lengths, used
with diverse groups, in assorted settings (Bien et al., 1993; Miller & Wilbourne, 2001;
Moyer et al., 2002; Tevyaw & Monti, 2004). Therapeutic components of brief
interventions may include: motivational interviewing, advice, education, counseling,
feedback, behavior contracting, or self-control training (Miller & Wilbourne, 2001).
Although brief interventions are, by definition, shorter in duration than more extensive
traditional behavioral therapy, there is wide variation in the length of treatments given
this designation. Brief interventions can be delivered opportunistically in a primary care
setting as a single 5- to 10-minute event for nontreatment-seeking individuals, or
conducted by a therapist over three to four sessions for individuals seeking treatment for
specific problem behaviors (Moyer et al., 2002). Despite this wide variation, brief
interventions have been found effective in reducing the incidence of harmful alcohol use
with a variety of populations across a wide range of settings (Bien et al., 1993; Kaner et
al., 2007; Miller & Wilbourne, 2001; Moyer et al., 2002; Perl, 2001; Vasilaki et al., 2006;
Wilk, Jensen, & Havighurst, 1997).
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Brief intervention efficacy in the general population. Researchers have
measured the impact of brief interventions on alcohol consumption among the general
populations. Meta-analyses of findings of similar studies showed a significant benefit
associated with brief interventions; all reported small to medium aggregate effect sizes in
support of brief intervention groups as compared to control groups (Kaner et al., 2007;
Moyer et al., 2002; Vasilaki et al., 2006; Wilk et al., 1997). Brief interventions were more
effective with heavier drinkers (Kaner et al., 2007; Vasilaki et al., 2006; Wilk et al.,
1997), a finding not supported in the study by Moyer and colleagues (2002), who found
larger effect sizes when heavy drinkers were removed from the analysis. Treatmentseeking patients received greater benefit from brief intervention (Moyer et al., 2002) or
no significant difference in effect (Vasilaki et al., 2006) compared to nontreatmentseekers. One study found greater effect sizes among men as compared to women (Kaner
et al., 2007), a finding that was not corroborated in other reviews (Moyer et al., 2002;
Vasilaki et al., 2006; Wilk et al., 1997). Aspects of time were considered in some of the
analyses. While Wilk et al., (1997) found that effect size increased with more than one
session, no significant difference in effect size was associated with the length of the brief
intervention (Kaner et al., 2007; Moyer et al., 2002; Wilk et al., 1997). Effect sizes were
largest at earlier follow-ups and tended to degrade over time and (Moyer et al., 2002;
Vasilaki et al., 2006).
These studies provide support for the role of brief interventions in reducing
harmful drinking among heavy drinkers in the general population. They also highlight the
value that a preponderance of controlled studies plays in demonstrating relationships and
causality.
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Brief interventions with pregnant women. Brief interventions have been
reported to benefit pregnant, substance-using women (Armstrong et al., 2003; G. Chang
et al., 2005; Ferreira-Borges, 2005; O'Connor & Whaley, 2007). The American College
of Obstetricians and Gynecologists (2008) recommends universal ATOD screening
followed by brief interventions and appropriate referrals for ATOD-positive pregnant
women.
Four randomized controlled studies analyzed the impact of brief interventions on
prenatal alcohol consumption. Pregnant women identified at risk for prenatal alcohol
intake were randomized to experimental groups receiving brief educational interventions
(Chang et al., 2005; Chang, Wilkins-Haug, Berman, & Goetz, 1999; O'Connor &
Whaley, 2007) or motivational interviews (Handmaker, Miller, & Manicke, 1999).
O’Connor and Whaley (2007) reported a 5-fold increase in days of abstinence among
women in the brief intervention group (F[1.241] = 4.33, p < .04). G. Chang and
colleagues (2005) found that an already significant reduction in prenatal alcohol
consumption in the treatment group (b = - 0.163, SE [b] = 0.063, p < .01) was magnified
when the woman’s partner was present for the intervention (b = - 0.932, SE [b] = 0.468, p
< .05). In the other two studies, the difference in alcohol intake between control and
intervention groups did not reach statistical significance (Chang et al., 1999; Handmaker
et al., 1999).
Neonatal measures have been analyzed to assess the effect of brief interventions
given to substance-using pregnant women (Armstrong et al., 2003; O'Connor & Whaley,
2007). Researchers compared the fetal mortality rate of two groups of pregnant women
participating in the Supplemental Nutrition Program for Women, Infants, and Children
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(WIC) who had alcohol-positive screening results (O'Connor & Whaley, 2007). Infants
born to women who had received a 15-minute brief intervention from WIC nutritionists
were heavier (F [1.194] = 3.59, p < .06), and longer (F [1.194] = 4.48, p < .03) at birth in
comparison to the infants born to the women in the control group who received
assessment and advice to stop drinking. Other investigators compared neonatal outcomes
of infants born to ATOD-positive pregnant women who (a) received a screening only, (b)
received a screening and an assessment, or (c) received screening, assessment, and a brief
intervention, with a control group of women who had screened negative for ATOD use
(Armstrong et al.). Chi-square analysis revealed no significant difference in the incidence
of preterm delivery, birth weight, or assisted ventilation rate between the brief
intervention and control groups (all p values > 0.17). Conversely, significant differences
were noted on all three outcomes for the other two groups of ATOD-using women in
comparison to the control (all p values < 0.0024).
The effectiveness of brief interventions among pregnant tobacco smokers has
been studied. Ferreira-Borges (2005) found that women in the brief intervention
experimental group had significantly higher levels of tobacco abstinence at a 2-month
follow-up assessment compared to the women in the control group (x2 = 4.93, p = 0.02).
In another randomized controlled trial with methadone-maintained, nicotine-dependent
pregnant women, no significant difference in reduction of tobacco use between the brief
intervention and control groups was observed (Haug et al., 2004). The complex
psychosocial issues associated with opioid-dependent pregnant women limit the
generalizability of these findings.
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Although there have been relatively few studies conducted with pregnant women,
brief interventions have demonstrated some effectiveness in reducing prenatal substance
use and exerting a beneficial impact on neonatal outcomes. Further controlled research
incorporating assessment of treatment fidelity is needed to determine the effectiveness of
specific brief interventions and to facilitate replication in the primary care prenatal
setting.
Non-specialist brief intervention implementation. Another promising avenue of
study is determining the relative effectiveness of brief intervention by non-specialists.
Although most brief intervention research has used physicians or research staff to
implement the interventions, there are a few studies that have examined this treatment
modality with non-specialists.
Investigators compared the provider-specific frequency of brief intervention
implementation for patients who screened positive for harmful levels of alcohol use by
two levels of providers in a multi-site study (Babor, Higgins-Biddle, Dauser, Higgins, &
Burleson, 2005). Under one study condition, medical providers (physicians, physician
assistants or nurse practitioners) delivered the brief interventions. In the other condition,
brief interventions were implemented by mid-level professionals (nurses or health
educators). Researchers found that mid-level professionals screened a higher percentage
of patients than medical providers (24% and 19% respectively) and, among those patients
screening positive, more patients in the mid-level condition received a brief intervention
(73.1% versus 57.1%). This study focused solely on the frequency of implementation and
did not measure comparative alcohol intake reduction.
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Gamma-glutamyl transferase (GGT), a liver function test capable of detecting
chronic alcohol intake (Pagana & Pagana, 2009), was the pre-treatment and posttreatment measurement used to determine the effectiveness of a brief intervention
delivered by a nurse to patients identified as heavy drinkers (Tomson, Romelsjo, &
Aberg, 1998). The mean GGT values (measured in microkatals per liter) in the nurseinterventionist treatment group had decreased significantly from 1.52 at baseline to 1.21
at the 2-year follow-up (p = 0.02), while the GGT values of the control group receiving
traditional physician advice increased from 1.74 to 2.16 (p = 0.34).
In the study conducted by O’Connor and Whaley (2006), WIC nutritionists
implemented brief interventions for pregnant women. This is the only prenatal study that
has used nonmedically trained health professionals as interventionists. To date, no studies
have been published measuring the effectiveness of brief interventions conducted by
frontline staff in reducing ATOD use during pregnancy.
Brief intervention cost-effectiveness. Fleming and colleagues (2002) estimated
economic costs and benefits associated with physician-conducted brief interventions for
the treatment of problem drinking. A randomized, controlled clinical trial was performed
to evaluate the long-term effectiveness of a brief intervention delivered to patients who
screened positive for at-risk drinking. The trial found sustained reductions in alcohol use
in the treatment group over the 48-month follow-up period. These researchers also
performed a complex benefit cost analysis that estimated a net benefit of $7,780 per
patient receiving the brief intervention. The calculated differential in cost savings
between the two groups was derived from medical care savings (emergency department
visits and hospitalizations), avoidance of legal events (e.g., arrests for assault, abuse,
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theft, disorderly conduct, property damage), and motor vehicle events (driving under the
influence, crashes, and fatalities). The results of this study provide compelling evidence
in support of using brief interventions to treat problem drinking in terms of cost as well as
efficacy.
Treatment Fidelity
In the 1950s, as new schools of psychoanalytic thought arose and the incidence of
comparative behavioral therapy outcome research increased, the scientific community
began to voice concerns regarding the reported effectiveness of psychotherapeutic
interventions (Luborsky, Singer, & Luborsky, 1975). This literature review section
presents a chronology of the development of treatment fidelity, which emerged as a
methodological strategy to address these concerns. Significant procedural aspects
associated with the assessment of treatment fidelity will also be explored.
History of treatment fidelity. Eysenck (1952) challenged hypotheses that
psychotherapy facilitated recovery from neuroses. He summarized the results of
descriptive studies that reported improvement of neurotic patients after psychotherapy
and compared these findings using statistics derived from hospital records and disability
claims to estimate percentages of similar patients who recovered without benefit of
psychotherapy. He deduced an aggregate recovery rate of 72% for patients receiving no
psychotherapy (under the care of a general practitioner or in custodial treatment), while
only 66% of patients receiving psychotherapeutic treatment recovered. Eysenck
acknowledged the shortcomings of his actuarial comparison but nevertheless concluded
that his findings raised serious concerns regarding the results of studies reporting
favorable effects of psychotherapy. His recommendation for further “carefully planned
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and methodologically more adequate” (p. 323) experimental research to provide reliable
evidence regarding the efficacy of psychotherapy was an early harbinger of the scientific
community’s recognition of the importance of identifying research strategies assuring
accurate, faithful treatment delivery.
A comprehensive evaluation of controlled comparative treatment research, a field
of study that began in the middle 1950s, reported that the studies reviewed rarely offered
evidence that the delivered treatment actually corresponded to the intended treatment
(Luborsky et al., 1975). Insignificant differences were noted between psychotherapeutic
models in terms of their demonstrated effectiveness, leading investigators to conclude
that patients tend to benefit from any therapy that involves a helping relationship with a
therapist.
The concept of fidelity, introduced in 1981, was defined as the faithfulness with
which researchers and clinicians implemented behavioral treatments (Yeaton & Sechrest,
1981). The authors coined the terms “treatment strength” to refer to the “ a priori
likelihood that the treatment could have its intended outcome” (p. 156) and “treatment
integrity” as “the degree to which treatment is delivered as intended,” (p. 160) and argued
that any determination regarding the appropriateness of a treatment should only be made
after attending closely to both strength and integrity.
A review of applied behavioral research literature published between 1968 and
1980, reported that, although articles consistently contained reliability estimates of the
dependent variable, 80% failed to report adequate efforts to ensure integrity of the
independent variable (Peterson, Homer, & Wonderlich, 1982). The lack of
methodological rigor created doubt about the quality of data and conclusions resulting
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from these studies, and recommendations included intensive interventionist training and
incorporation of a method to measure the accuracy of treatment delivery to ensure
accurate application of the independent variable.
A “technology model” of research design and implementation proposed using the
same precision and rigorous methodology applied to pharmacology trials when carrying
out behavioral therapy research (Carroll & Rounsaville, 1990). To protect the
independent variable and enhance internal validity, this approach specified manualguided treatment, thorough operationalization of treatment delivery, interventionist
training, and ongoing supervision of treatment implementation.
The term “treatment fidelity” was first introduced in a survey of psychosocial
therapy outcome literature culled from major journals published between 1980 and 1988
(Moncher & Prinz, 1991) Among the 359 treatment outcome studies evaluated, over half
made no mention of design methods to address treatment fidelity.
A review of prevention program outcome evaluation literature was conducted to
determine the degree to which the programs were implemented as planned (Dane &
Schneider, 1998). When behavioral intervention studies published between 1980 and
1994 were examined, investigators found that only 24% of the programs incorporated
procedures to verify program integrity. In addition, they noted that, although the major
journals containing most of the studies included in the sample stipulated inclusion of
program integrity strategies as a prerequisite of publication acceptance, these
requirements appeared to have been loosely enforced.
Rounsaville, Carroll, and Onken (2001) discussed the evolution of treatment
efficacy research and the mandate placed on investigators to develop treatment manuals
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and valid methods of evaluating treatment fidelity in order to qualify for governmentfunded research support. They reported that, due to the considerable effort involved in
addressing treatment fidelity in advance of conducting randomized clinical trials, the
National Institute on Drug Abuse had developed the “Stage Model of Behavioral
Therapies Research.” The model demarcates three distinct stages of research and
advocates research-funding support at each level to encourage development and testing of
innovative therapies. Appropriate stage-one research activities include the development
of programs, manuals, training, fidelity measures, and pilot testing.
A meta-analysis of the treatment fidelity practices reported in health behavior
change outcome literature between 1990 and 2000 reported no significant increase in the
frequency with which researchers addressed the issue of treatment fidelity (Borrelli et al.,
2005). Of the articles analyzed, 54% failed to identify inclusion of strategies necessary to
monitor the reliability and validity of behavioral interventions.
A review of randomized controlled trials testing the efficacy of psychotherapeutic
interventions was published between 2000 and 2004 (Perepletchikova, Treat, & Kazdin,
2007). Investigators found that, although the evaluative measures used to determine
adequacy were consistent with those recommended in the literature, only 3.5% of the
studies reported implementation of adequate treatment fidelity procedures. They also
noted that researchers consistently devoted greater attention to reliability and operational
definitions of behaviors serving as outcome measures, than to those associated with the
independent variable, echoing an observation made 25 years earlier (Peterson et al.,
1982).
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Rationale for assessing treatment fidelity. Strategies allowing assessment of
treatment fidelity are requisite components of submissions for government grant funds
and referred journal publications. Nevertheless, most of the investigators who have
conducted comparative psychotherapy research have failed to address treatment fidelity
despite the increasing emphasis placed upon this by the scientific community. Rationale
articulated in the literature regarding the importance of incorporating treatment fidelity
processes in psychotherapy research include considerations involving external validity,
internal validity, statistical analyses, interventionist training, and feasibility of treatment.
External validity. Research is generally not conducted solely to discover
relationships among variables for the individuals participating in the study, but also to
reach conclusions that can benefit populations extending beyond the study sample (Polit
& Hungler, 1999). External validity refers to generalizability, or the degree to which the
results of the study would hold with other populations, in other places, and with
alternative measurement instruments (Campbell & Stanley, 1966). Research results that
can be generalized to other settings and samples are said to have a high degree of external
validity (Campbell & Stanley, 1966).
A relevant aspect of external validity in relation to treatment fidelity pertains to
the focus on translation of research findings into practice settings. There are advantages
in a study that provides unambiguous treatment guidelines and clear documentation of the
procedures used to assess the quality of implementation. When a study incorporating
these procedures reports that an effective treatment was implemented with high fidelity,
the opportunity for dissemination of effective treatments across the research-practice gap
is increased (Bellg et al., 2004; Dumas, Lynch, Laughlin, Smith, & Prinz, 2001; Spillane
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et al., 2007).
Treatment fidelity is critical to the maintenance of external validity in controlled
psychotherapy research. The processes involved in treatment fidelity assessment require
clear identification of treatment content; this is also necessary for replication of results
(Moncher & Prinz, 1991). Use of a treatment manual has been identified as essential to
the conduct of behavioral treatments in clinical trials to standardize interventionist
training, and to reduce implementation variance (Rounsaville et al., 2001). A review of
health behavior change outcome studies published between 1990 and 2000 noted that
35% reported use of a treatment manual (Borrelli et al., 2005); a similar review of studies
published between 2000 and 2004 found that 65% reported use of a specific treatment
protocol (Perepletchikova et al., 2007). This change in the frequency of use of treatment
manuals is significant and may herald a trend.
Use of a treatment manual alone is insufficient to protect against threats to
external validity. While a detailed description of proper implementation is necessary, it is
also necessary to assess, verify, and document the quality of treatment implementation
(Dumas et al., 2001; Peterson et al., 1982). These activities comprise the core of
treatment fidelity and must be built into study methodology before a legitimate evaluation
of treatment efficacy can occur.
Internal validity. When the goal of research is to establish a causal relationship,
internal validity is a primary consideration (Trochim & Donnelly, 2007). Internal validity
refers to the degree that it is possible to infer that the effect on the dependent variable was
actually produced by the independent variable rather than resulting from extraneous
variables (Campbell & Stanley, 1966). Faithful delivery of the independent variable is a
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hallmark of controlled research. When the independent variable takes the form of a drug
in a randomized controlled trial, it may be sufficient to simply report the dosage and route
of administration. However, when a randomized controlled trial is conducted to compare
the efficacy of psychotherapeutic treatment with an alternative control treatment, it is
insufficient to simply state in the method section that a given treatment was implemented
(Peterson et al., 1982). The implementation of a complex behavioral treatment by an
interventionist is much less straightforward, and a fair comparison to the control depends
on methodological assurances that the intended treatment was actually delivered as
designed (Luborsky et al., 1975; Moncher & Prinz, 1991; Peterson et al., 1982).
Compromises to internal validity may result from inaccurate interventionist
implementation such as the omission of prescribed treatment components or the addition
of proscribed components (Borrelli et al., 2005; Moncher & Prinz, 1991; Perepletchikova
et al., 2007). Thus, significant results could actually be due to an effective treatment or a
Type I error that occurred because unintended ingredients were added to the intervention.
Conversely, insignificant results could be the result of a weak treatment or a Type II error
due to inadequate administration of the intervention (Borrelli et al., 2005; Moncher &
Prinz, 1991; Perepletchikova et al., 2007; Polit & Hungler, 1999). Regardless of whether
research findings note a large treatment effect or lack of effect, failure to address
treatment fidelity issues erodes confidence in the study outcomes (Bellg et al., 2004;
Borrelli et al., 2005; Luborsky et al., 1975; Moncher & Prinz, 1991; Perepletchikova et
al., 2007; Peterson et al., 1982).
Statistical analysis. Attention to treatment fidelity improves statistical power by
reducing unintended variability in treatment effect due to uneven delivery by
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interventionists (Dumas et al., 2001; Yeaton & Sechrest, 1981). Because sample size is
another invariant factor in the calculation of statistical power, attention to treatment
fidelity may reduce study costs. As power increases, a proportionately smaller sample
size can be used in a test of statistical significance (Bellg et al., 2004; J. Cohen, 1977;
Resnick et al., 2005).
Rather than an all-or-none occurrence, treatment fidelity is a phenomenon that can
be conceptualized as falling along a continuum measuring the extent of intervention
exposure (Moncher & Prinz, 1991). This operationalization allows treatment fidelity to
be used as a direct factor in statistical analyses. If fidelity assessment involves measuring
the degree of intervention actually received, this “intervention dosage” can be inserted as
an independent variable into a regression analysis (Sidani, 1998).
Treatment fidelity measures can be quantified and used in data analyses to
determine degrees to which results are due to study intervention. In a longitudinal, multisite study measuring the effectiveness of a cognitive-behavioral approach to substance
abuse prevention, researchers identified a direct relationship between the extent of
program implementation and outcomes (Botvin, Baker, Dusenbury, & Tortu, 1990). They
found that participants receiving a higher intervention dose had correspondingly lower
levels of substance use than individuals receiving a lower dose.
Interventionist training and performance. Results of fidelity assessment can be
used as a feedback mechanism to enhance interventionist training and performance (J.
Waltz, Addis, Koerner, & Jacobson, 1993). Evaluation of treatment fidelity illuminates
lapses in implementation and facilitates identification of interventionists in need of
training augmentation (Carroll, Nich, & Rounsaville, 1998; Resnick et al., 2005; J. Waltz
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et al., 1993). Additionally, treatment fidelity assessment tends to encourage optimal
adherence to the treatment protocol by interventionists (Borrelli et al., 2005).
Treatment feasibility. Assessment of treatment fidelity provides information
about the feasibility of implementing a treatment protocol in practice (Dusenbury,
Brannigan, Falco, & Hansen, 2003). If treatment interventions were difficult to
implement with adequate fidelity, steps can be taken to redesign the protocol to enhance
outcomes.
Components of treatment fidelity. Also referred to as treatment integrity (Dane
& Schneider, 1998; J. Waltz et al., 1993; Yeaton & Sechrest, 1981), fidelity of
implementation (Dusenbury et al., 2003), and intervention fidelity (Santacroce,
Maccarelli, & Grey, 2004), Treatment fidelity is a relatively nascent concept described in
the literature (Dusenbury et al., 2003). There is general agreement that adherence and
competence are the key elements of treatment fidelity.
Adherence. Adherence is a component of treatment fidelity that describes the
degree to which the essential processes associated with the treatment protocol are
implemented and prohibited elements are avoided (Dane & Schneider, 1998; Dusenbury
et al., 2003; Moncher & Prinz, 1991; Santacroce et al., 2004; Stein et al., 2007).
Measurement of adherence requires operationalization of the unique elements that
distinguish a particular treatment protocol to determine the extent to which the guidelines
are followed during implementation (Carroll et al., 2000; Mowbray, Holter, Teague, &
Bybee, 2003).
Competence. The second major aspect of treatment fidelity is competence, which
is the level of interventionist skill during implementation or quality of treatment (Barber,
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Liese, & Abrams, 2003; Hogue, Liddle, & Rowe, 1996; J. Waltz et al., 1993).
Measurement of competence involves operationalization of treatment elements that
distinguish the manner in which the interventionist delivers the treatment and may
include contextual behaviors such as communication of empathy, collaboration,
responsiveness, and sensitivity (Hogue et al., 1996; J. Waltz et al., 1993). Indicators of
competence should be theoretically derived from the specific treatment protocol rather
than from general concepts of therapeutic behaviors (J. Waltz et al., 1993). As the
meaning underlying an interventionist behavior varies, depending on the client context in
which it occurs, measurement of treatment competence is a more subtle and complex
process than measurement of adherence (Hogue et al., 1996; J. Waltz et al., 1993).
High fidelity implementation requires both adherence and competence (Hogue et
al., 1996). Competent implementation is impossible without adherence to treatment
guidelines; yet adherence alone is insufficient to assure competent delivery (Barber et al.,
2003; Perepletchikova et al., 2007; J. Waltz et al., 1993).
Treatment fidelity measurement. The measurement of treatment fidelity
involves identifying theoretically distinctive intervention elements to ensure reliable
differentiation among treatments when conducting comparative research (Dane &
Schneider, 1998; Hogue, Liddle, Singer, & Leckrone, 2005; Moncher & Prinz, 1991;
Santacroce et al., 2004; Stein et al., 2007). The extent to which treatments differ from
each other can be sufficiently determined through the development of detailed, precise,
protocol-derived measures that include proscribed as well as prescribed behaviors
(Mowbray et al., 2003; J. Waltz et al., 1993).
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Treatment manuals. A detailed manual that describes the treatment protocol is an
essential precondition of treatment fidelity assessment (Rounsaville et al., 2001; J. Waltz
et al., 1993). Although the existence of a treatment manual cannot ensure purity of
implementation, it does increase the likelihood of consistent, standardized delivery (Bellg
et al., 2004). Treatment manuals should clearly specify appropriate interventions and
desired therapeutic behaviors to guide training, implementation, and identification of
fidelity assessment criteria (Rounsaville et al., 2001; Santacroce et al., 2004). In addition,
theoretical foundation and therapeutic objectives are appropriately explicated in the
treatment manual (Bellg et al., 2004; Mowbray et al., 2003; Santacroce et al., 2004).
Although manual-guided treatment protocols are the recognized standard,
treatment fidelity studies inconsistently use manuals (Bellg et al., 2004; W. R. Miller &
Wilbourne, 2001; Mowbray et al., 2003; Perepletchikova et al., 2007). In addition, when
manuals have been developed to guide psychotherapeutic treatments, they seldom
provide adequate detail regarding competence criteria (J. Waltz et al., 1993).
Instrument design. The design of treatment fidelity instruments differs
significantly in accordance with the treatments they have been developed to measure.
Complex treatment protocols require tools of correspondingly greater complexity to
assess interventionist adherence and competence (Ogrodniczuk & Piper, 1999; Orwin,
2000; Perepletchikova et al., 2007; Stein et al., 2007; J. Waltz et al., 1993). However,
lengthy, complicated measures can become unwieldy and impractical to use
(Ogrodniczuk & Piper, 1999). Congruence with the theoretical assumptions underlying
the interventions is a primary consideration when developing a fidelity measurement tool
(J. Waltz et al., 1993).
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Scale design. The construction of scale items also varies widely. A simple and
economical design involves a checklist format, rating the incidence and frequency of
prescribed or proscribed interventions (J. Waltz et al., 1993). This method can obscure
subtle differences in interventionist behaviors and may hamper assessment of inter-rater
reliability resulting from difficulty detecting differences between coding scores (Stein et
al., 2007). Advantages of dichotomous measures include their economy, simplicity, and
elimination of outliers (Stein et al., 2007; J. Waltz et al., 1993). A Likert format is an
alternative item design allowing ratings of frequency or intensity of a given behavior
(DeVellis, 2003). Likert scaling is more complex than dichotomous scaling, requiring
more intensive rater training to achieve satisfactory inter-rater reliability (J. Waltz et al.,
1993).
Treatment fidelity data collection. Measurement of treatment fidelity requires
collection of implementation data. A variety of strategies can be used to accomplish this.
Direct methods include audiotapes, video recordings, and in vivo observation of
implementation, while indirect methods rely on evidence obtained from sources such as
therapist self-reports, process note review, and checklists (Perepletchikova et al., 2007; J.
Waltz et al., 1993). Although direct measures are more complex and costly than indirect
methods, they are considered the gold standard for collection of fidelity evidence for
research (Bellg et al., 2004; Santacroce et al., 2004; Stein et al., 2007). Studies have
found that therapists tend to over-report implementation of psychotherapeutic
interventions in comparison to the assessment of independent raters (Carroll et al., 1998;
Chevron & Rounsaville, 1983). While indirect methods can play a valuable role in the
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training and maintenance of treatment fidelity, they cannot substitute for measures
involving direct observation (J. Waltz et al., 1993).
Another important aspect of treatment fidelity measurement is identifying the
appropriate unit of treatment to be used in the fidelity analysis. Approaches that have
been used in treatment fidelity research include event-by-event coding, in which each
therapist utterance is identified as a scoring unit (Wills, Faitler, & Snyder, 1987), scoring
randomly selected session segments (Luborsky, McLellan, Woody, O'Brien, & Auerbach,
1985), and coding entire sessions (Carroll et al., 2000).
Concrete, observable therapist behaviors are specific aspects of the codeable unit
that need to be considered when assessing treatment fidelity (J. Waltz et al., 1993).
Focusing on actions of the interventionist helps to distinguish implementation from client
response behaviors and facilitates measurement of treatment fidelity (Santacroce et al.,
2004).
Interventionist training. Adequate interventionist training is essential to
establish and maintain treatment fidelity (Bellg et al., 2004; Moncher & Prinz, 1991;
Resnick et al., 2005). The purpose of training is to teach new skills, expand and refine
existing abilities, preserve implementation quality, and minimize drift from the original
protocol (Bellg et al., 2004; Hogue et al., 1996; Santacroce et al., 2004). Standardized
training is important to optimize consistency of implementation by interventionists (Bellg
et al., 2004; Rounsaville et al., 2001). Use of treatment protocol training manuals
facilitates training standardization (Bellg et al., 2004; Resnick et al., 2005; Santacroce et
al., 2004). Training variance can be further minimized by having the same instructors
conduct workshops when multiple sessions are planned (Bellg et al., 2004).
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No single training approach has demonstrated superiority; however interactive
teaching strategies that use peer performance feedback have been effective (Grol &
Grimshaw, 2003). A manual-based curriculum disseminated through didactic instruction
integrated with experiential teaching strategies such as intervention role-playing has been
recommended (Bellg et al., 2004; Moncher & Prinz, 1991; Resnick et al., 2005;
Santacroce et al., 2004).
Rater selection and training. The selection of raters who will make judgments
regarding the quality of implementation is a critical aspect of treatment fidelity research.
Raters selected to assess and code treatment fidelity should possess expertise comparable
to that of the interventionist (Moras & Hill, 1991; Stein et al., 2007; J. Waltz et al., 1993).
The complexity of the fidelity instrument and the degree of difficulty involved in
measurement should also be considered when determining rater qualifications.
Instruments with specific rating systems based on clearly identifiable interventionist
behaviors may be used successfully by individuals with less expertise, while tools
requiring consideration of more subtle contextual variables will benefit from raters with
more experience (J. Waltz et al., 1993). Raters should be not be directly involved in the
research project; recruitment of unaffiliated individuals will reduce rating bias and
enhance study reliability and validity (Dumas et al., 2001; Hogue et al., 1996; J. Waltz et
al., 1993).
Rater training should include teaching components similar to those used to train
interventionists (Carroll, Kadden, Donovan, & Zweben, 1994; Hogue et al., 1996; Stein
et al., 2007; J. Waltz et al., 1993). Detailed, manual-based treatment protocol instruction
is recommended to ensure that raters comprehend intervention strategies and goals
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(Carroll et al., 2000; Hogue et al., 1996; Stein et al., 2007; J. Waltz et al., 1993). Rater
instruction should include opportunities to code practice audio recordings or videotapes
of pilot cases (Carroll et al., 2000; Dumas et al., 2001; Moncher & Prinz, 1991; Stein et
al., 2007). Subsequent comparison of trainee results with expert consensus ratings of the
same tapes will allow determination of inter-rater reliability (Carroll et al., 2000; Stein et
al., 2007). Another teaching strategy to facilitate measurement calibration and enhance
inter-rater reliability is to foster regular discussion among raters regarding their mutual
interpretation of interventionist behaviors and comparison of ratings (Carroll et al., 2000;
Dumas et al., 2001; Moras & Hill, 1991).
Treatment fidelity assessment in brief intervention research . Assessment and
measurement of treatment fidelity is a fundamental component of empirical testing
conducted to determine whether a psychosocial intervention, found to be effective in a
controlled trial, is generalizable and replicable. An extensive review of the prenatal
substance use brief intervention research found only two studies reporting incorporation
of treatment fidelity procedures.
Researchers conducted a randomized clinical trial to measure change in maternal
alcohol use when partners as well as pregnant women participated in a single-session
brief intervention (Chang et al., 2005). There is no mention of a manual; the authors
describe the intervention as structured, incorporating knowledge assessment, goal setting,
and behavioral modification. Implementation was conducted by the primary investigator
(a psychiatrist) or master’s-degree-prepared nurse practitioners; all were described as
clinicians experienced in delivery of the brief intervention. The method used to assess
treatment fidelity was evaluation of interventionist summary notes. Interventions were
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not audiotaped and there was no report of use of a fidelity measurement tool or the degree
of treatment fidelity attained during implementation. As described earlier, G. Chang
(2005) and colleagues reported significant declines in alcohol consumption in the brief
intervention group. However, replicability of this study was jeopardized by limitations in
several of the reported treatment fidelity procedures including (a) lack of a specific
treatment protocol or quality control methods to assure fidelity in treatment delivery, (b)
subjective assessment of implementation, and (c) failure to develop and implement
methods to measure treatment fidelity.
In another controlled trial, O’Connor and Whaley (2007) studied the effectiveness
of a brief intervention designed to encourage pregnant women to abstain from alcohol.
This manual-guided brief intervention is described as incorporating education, cognitivebehavioral procedures, and goal setting. Interventionists were nutritionists who had
received training. A fidelity checklist was used to assess inclusion of brief intervention
content. Before participating in the study, interventionists were required to demonstrate
100% reliability in conduct of the brief intervention when assessed by means of the
fidelity checklist. A random sample of interview sessions were audiotaped during the
study and scored using the fidelity checklist to ensure continued adherence to the
protocol. Higher rates of abstinence and improved infant outcomes were reported among
women receiving the brief intervention. The treatment fidelity methods described in this
study encompass many criteria essential for intervention replication, including (a)
provision of a manual detailing a specific treatment protocol, (b) intensive training
measures taken to ensure quality of implementation, (c) objective assessment of
implementation, and (d) use of a fidelity checklist to assess adherence to intervention
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content. Treatment integrity would have been further strengthened if methodological
procedures had been incorporated to facilitate assessment of interventionist competence
and evaluation of audiotapes by unaffiliated raters.
Gaps in the Literature
Brief intervention studies carried out with the general population and with
pregnant women have reported significant reductions in harmful substance use, yet few
of these efficacious interventions have been successfully translated from the research
setting. It is clear that conducting a rigorous, randomized controlled clinical trial is not
enough to ensure that an intervention will be used in practice. Most brief intervention
studies have not sufficiently incorporated research strategies that are needed to assure
faithful delivery of behavioral treatments, determine their effectiveness, and facilitate
adoption.
The dearth of brief intervention studies using non-specialists or frontline staff in
the role of interventionist draws attention to another area that warrants study. The
increasingly costly nature of healthcare mandates investigation of cost-effective
intervention protocols that reflect the reality of standard staffing in primary health care.
This literature review, by presenting what is known about prenatal substance use,
brief intervention research, and treatment fidelity, has revealed topics that merit further
examination. These areas frame the contribution that this study will make to the current
knowledge.
Summary
This chapter presented a review of the literature relevant to this study. MI and
SDT concepts were aligned to provide a sturdy conceptual framework that guided
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development of the treatment fidelity instrument. An overview of deleterious effects
associated with prenatal consumption of alcohol, tobacco, marijuana, opioids, cocaine,
and amphetamines was presented. A chronology of historic events in the scientific
community provided rationale for the emergence of treatment fidelity. The importance of
assessing treatment fidelity in the controlled study of experimental behavioral
interventions was illuminated. There is convincing evidence in support of brief
interventions in terms of efficacy, efficiency, and cost-effectiveness. Although the
literature has contributed positive information regarding the promise of brief
interventions in reducing substance use during pregnancy, there is a need for a controlled
brief intervention research study with this population that incorporates rigorous treatment
fidelity strategies sufficient to assure delivery of the independent variable. It is this gap in
the literature that I sought to address in this study.
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Chapter 3
Methods
This chapter presents a description of the IAC brief opportunistic intervention
followed by a detailed outline of the methods and procedures that were used in the study.
The research design, sample, setting, institutional approval of methods for protection of
human participants, data collection procedure, instrumentation, and data analyses are
addressed.
IAC Brief Opportunistic Intervention
The IAC is a structured, substance-specific protocol developed to facilitate timely
provider response to the disclosure of ATOD use during pregnancy. The steps of the IAC
are outlined in a manual (Chasnoff & McGourty, 2003) that includes scripted options and
suggested language for the interventionist to use depending on the woman’s response.
The manual contains photographs of substance-exposed children manifesting clinical
effects of prenatal alcohol, tobacco, or illicit drugs. The photographs are accompanied by
text that describes the potential consequences of use. Per IAC protocol, the interventionist
displays photographs depicting negative outcomes associated with the specific substances
that the woman has reported using and discusses their potential consequences during
pregnancy.
Remarks are prefaced with the words “I am concerned…” when discussing
negative sequelae associated with prenatal substance use to avoid conveying an
intimidating or threatening attitude. Women are unambiguously advised to discontinue,
rather than decrease, ATOD use. The interventionist continuously assesses the woman’s
demeanor and responsiveness throughout the intervention to determine her reaction, and
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modify the approach accordingly. If the woman becomes distressed, the interventionist is
advised to yield in the interest of maintaining a therapeutic relationship, and defer further
treatment until a future opportunity presents itself. Referrals to drug, alcohol, or smoking
cessation will be offered as indicated. If the woman is open to referral, the provider will
facilitate an appointment to the appropriate source.
Research Design
I used a methodologic research design to frame the development of a treatment
fidelity instrument used to measure the degree of adherence and competence with which
frontline staff members implemented the IAC brief opportunistic substance-use targeted
intervention in the simulated prenatal clinic setting. I also assessed measurement validity
and reliability associated with use of this instrument.
Research protocol. I conducted this study in six phases, including (a) tool
development, (b) standardized patient hiring and preparation, (c) rater hiring and training,
(c) frontline prenatal clinic staff recruitment and preparation, (d) brief opportunistic
intervention implementation simulation, and (e) treatment fidelity coding and scoring.
Each of these phases is described in detail as follows:
Phase I: Tool development.
Step 1: Identification of essential elements of the IAC. I identified the essential
elements involved in accurate implementation of the IAC brief opportunistic intervention
from the manual describing the clinical protocol. Guided by the conceptual framework
derived from the union of MI and SDT, I used these elements to develop the instrument
that would be used to assess treatment fidelity during IAC implementation.
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Step 2: Construction of scale items. Once I identified the essential components
involved in IAC implementation, I translated them into statements of observable
interventionist behavior. The statements were arranged in accordance with the order in
which they were likely to be introduced during implementation. For any action that I
judged to comprise both adherence and competence components, I constructed paired,
sequenced statements using the same root phraseology to facilitate independent rater
recognition and scoring of the behavioral elements during implementation, a pattern I
adapted from the Yale Adherence and Competence Scale (Nuro et al., 2005).
Step 3: Development of item scaling Following development of the scale items, I
selected an appropriate scaling option to reflect the occurrence or non-occurrence of the
behaviors. I chose Likert scaling, which allows measurement of the intensity of behaviors
along a continuum, because it was most congruent with the complexity and assumptions
underlying the IAC treatment modality.
Step 4: Identification of coding units. The next step involved defining what was
to be treated as a codeable unit. Possible approaches range from coding timed segments
of a treatment session to identifying an entire session as a codeable unit. For this study,
the segment of the audio recording involving IAC implementation comprised the
codeable unit.
Step 5: Assessment of content validity. During this step of the tool development
phase, I sought the opinions of content experts I. J. Chasnoff and R. F. McGourty, the codevelopers of the IAC brief opportunistic intervention (Appendix A). I provided each
with a content review questionnaire that enabled them to judge the instrument’s specific
adherence and competence components in terms of how comprehensively they
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represented the underlying concepts of the IAC brief opportunistic intervention
(Appendix B). The questionnaire included 4-point rating scales to capture the content
reviewers’ assessment of the clarity and sufficiency of each scale item (1 = not very clear
or not sufficient, to 4 = clear or sufficient). The reviewers also judged the relevance of
each item to the content domain to determine if it should be deleted or retained, and
added comments as desired. The original draft contained 26 scale items (14 adherence
components and 12 competence components) that were framed as questions, each with a
5-point Likert scale with the scale anchors “not at all,” “a little,” “somewhat,” “quite a
bit,” and “extensively” (Appendix C).
Based on content expert feedback, I made several revisions to the first instrument
draft. I changed scale items from questions to declarative statements, revised Likert scale
anchors to reflect ordered levels of agreement, and included an “undecided” option to
provide a neutral middle value. I changed the Likert scale anchors for the competence
components to “strongly disagree,” “disagree,” “undecided,” “agree,” and “strongly
disagree.” For the adherence components, judged by the content experts to require a lessnuanced gradation, I assigned a 3-point scale labeled “disagree,” “undecided,” and
“agree.” In the second item, I changed the phrase “encouraging tone of voice” was
changed to “positive tone of voice” to clarify and enhance audible recognition of this
competence attribute. I developed new scale items to allow measurement of aspects of
implementation that had not been adequately addressed in the first draft, and I deleted
several items perceived to duplicate measurement of behaviors assessed by other items.
At this point, the revised instrument contained 19 items, 10 describing adherence
behaviors and 9 addressing competence behaviors (Appendix D). Of these items, I
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grouped 16 into sequenced pairs with an adherence statement describing implementation
of a specific behavior followed by a competence statement describing the quality of
implementation. I determined that item 7, “the interventionist conveys awareness of the
woman’s willingness to hear information regarding the effects of prenatal substance use,”
was a stand-alone overriding competence behavior. I judged that two remaining items
described independent adherence IAC behaviors: item 12 involved providing openings
for the woman to react, and item 15 addressed the referral of medical questions.
When the content experts reviewed the second draft of the IAC instrument, they
suggested additional modifications, and I further revised the instrument in accordance
with their comments. In items 13 and 14, I replaced the ambiguous phrase “providing
feedback” with “responding to the women’s reaction.” The content experts recommended
deleting item 15, “the interventionist verbalizes praise when acknowledging the woman’s
decision to discuss her drug use” because it would not apply to those women who chose
not to discuss their drug use. Moreover, they thought that acknowledging a woman’s
decision was the key element of this aspect of the IAC, and this had already been
addressed in item 14 as an adherence component. I made a final revision to the second
draft in accordance with content experts’ recommendation concerning item 19, “the
interventionist refers medical questions asked by the woman to the physician or nurse.”
Recognizing that some women would not have these questions, I added a “not
applicable” option. Finally, I incorporated these revisions into a third draft of the IAC
treatment fidelity instrument. The content experts endorsed this version without
recommending additional revisions (Appendix E).
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Step 6: Item testing and revision. Once the content experts deemed the IAC
treatment fidelity instrument satisfactory, I conducted preliminary testing. To accomplish
this, I hired as a research assistant, a clinical social work therapist who was skilled in the
implementation of the IAC brief opportunistic intervention. I used practice audio
recordings, made during simulated IAC implementation sessions with standardized
patients in the role of substance-using pregnant women and myself playing the role of a
frontline prenatal clinic staff member (see research protocol phase II, step 3), to conduct
the preliminary testing. Guided by the IAC treatment fidelity instrument, the therapist and
I independently evaluated, coded, and scored each of the practice audio recordings. We
then mutually reviewed our results and discussed the clarity and utility of the instrument.
On the basis of our review, we recognized that the competence items that corresponded to
adherence items needed a “not applicable” option to provide raters a scoring alternative
when IAC behaviors did not occur. The content experts approved this revision, resulting
in the fourth and final version of the IAC treatment fidelity instrument that I used during
data collection (Appendix F).
Phase II: Standardized patients.
Step 1: Standardized patient hiring. I recruited nine nursing students from the
associate degree nursing program of a local community college as standardized patients
to portray substance-using pregnant women. These students were paid as research
assistants.
Step 2: Standardized patient identities. I created realistic standardized patients
identities (Appendix G). The identities contained fictitious identity elements (name, age,
pregnancy history, partner status, medical history, history of substance use, and living
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conditions) upon which the students based their responses during the simulated
interviews. Three registered nurse prenatal clinic obstetric case managers evaluated the
identity scripts to ensure that they were realistic and reflective of actual patient cases.
Step 3: Standardized patient preparation. I met with the nursing students twice to
prepare them for their respective standardized patient roles. At the first meeting, I gave
the nursing students their scripted, standardized patient identities and described the
simulation plan. I held a second, individual meeting with each nursing student prior to the
beginning of data collection. At this time, the students participated in practice simulation
sessions during which I played the role of the frontline staff member. I conducted an
abbreviated prenatal intake interview, culminating in IAC implementation, with the
nursing students role-playing their standardized patient identities. I recorded these
interviews for future use in preliminary testing and revision of the treatment fidelity
instrument (see research protocol phase I, Step 6) and to facilitate rater training (see
research protocol phase III, step 2).
Phase III: Raters.
Step 1: Rater recruitment. I recruited three adjunct nursing faculty members from
the associate degree-nursing program of a local community college to serve as raters. The
faculty members were paid as research assistants.
Step 2: Rater training. I trained the raters using a curriculum that included
didactic training regarding the theoretical framework grounding brief interventions and
detailed discussion of IAC brief intervention implementation strategies (Appendix H). I
provided each of the raters with the IAC treatment manual that is used to train frontline
staff member in IAC implementation and as a guide during IAC implementation. In
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addition, I introduced the raters to the IAC treatment fidelity instrument and gave them
an opportunity to code and score the practice audio recordings that had been made during
standardized patient preparation (see research protocol phase II, step 3). To achieve
consensus and increase the level of inter-rater agreement, the raters and I reviewed and
discussed their codings and scores, with respect to the ratings that the therapist and I had
assigned.
Phase IV: Participant preparation. The frontline staff members recruited to
participate in the study had already received IAC brief opportunistic intervention
education in accordance with their job training. Prior to conducting the simulated clinic
interviews, I met with them as a group to review concepts associated with IAC
implementation and introduce them to the audio recording process that would be used
(Appendix I). At this meeting I sought guidance from the frontline staff participants
regarding the components that they thought necessary in an abbreviated prenatal intake
interview form that I planned to create for use during the simulations. Subsequent to the
meeting, I created this form and sent it to the participants via email for their approval
prior to their participation in the clinic simulations (Appendix J).
Phase V: Brief opportunistic intervention implementation. During the
simulated prenatal clinic sessions, the frontline staff participants met individually with
the simulated patients portraying their scripted identities. In private rooms arranged to
resemble a clinic office, the participants conducted prenatal intake interviews in
accordance with the same process used when performing their job duties in their prenatal
clinic or office. Each room was stocked with an IAC treatment manual and a sufficient
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number of prenatal intake forms for the participants to use when interviewing the
standardized patients.
At the beginning of each interview, I initiated a digital audio recording by
identifying the pseudonyms of the participant and the standardized patient. Because all of
the scripted identities assigned to the standardized patients resulted in eventual disclosure
of prenatal ATOD use during the course of the interview, each session contained a
segment during which the IAC brief opportunistic intervention was implemented.
At the completion of each clinic session, I collected the audio recording devices
and downloaded the digital files into a folder on my home office computer. I used the
pseudonyms identifying the participant interventionist and the standardized patient to
label each of the digital files.
Phase VI: Treatment fidelity coding and scoring. Subsequent to the completion
of the simulated clinic sessions, this 5-week long phase involving treatment fidelity
coding and scoring by the raters began. During each meeting, I gave the raters compact
discs containing 12 or 13 digital audio recordings labeled with pseudonyms designating
the participants and the standardized patients. In addition to the audio recordings, I
supplied raters with a corresponding number of copies of the IAC treatment fidelity
instrument. I shuffled the order of the audio recordings before creating each rater’s
compact disc to reduce the possibility of any systematic bias that could have affected the
assignment of scores. I randomized each rater’s weekly set of audio recordings using
playing cards by: (a) shuffling the deck three times, (b) placing a card face-up from the
top of the deck on slips of paper designating each of the audio recordings in order, and (c)
reordering the set of audio recordings from the highest to the lowest ranking card. Suit
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order from high to low was: spades, hearts, diamonds, and clubs; the ace was considered
a numeral one.
I directed the raters to listen independently to the audio recordings to determine
the section during which IAC implementation occurred and encouraged them to replay
the recordings as often as they deemed necessary to conduct a comprehensive appraisal.
Using the IAC treatment fidelity instrument, the raters assessed the adherence and
competence with which the specific IAC brief opportunistic intervention behaviors were
implemented and rated them according to the tool’s measurement scale, recording their
ratings on the tool. Raters used the IAC treatment manual to review implementation
concepts as needed and wrote comments describing any difficulty they experienced
assigning scores. I also evaluated and scored each of the audio recordings assigned to the
raters each week. This afforded me the opportunity to experience rating issues first-hand
and enhanced my ability to facilitate the weekly meetings. My ratings were used for
educative purposes only and were not included in statistical analyses.
I met weekly with the raters. At this time, the raters returned the previous week’s
audio recordings and completed fidelity tools, and they received a new set of audio
recordings and fidelity tools. During these meetings, to achieve and maintain high interrater reliability and prevent drift, the raters and I discussed in detail how their
measurement decisions had been made and any problems they had experienced in
assigning ratings the previous week. Ratings made prior to meetings were not changed
during or after the meetings.
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Setting
The study took place in a mid-sized county in central California. I developed the
IAC treatment fidelity instrument and standardized patient scripts at a desk in my home
office. The phases that involved preparation and training of standardized patients and
participants took place in a nursing classroom on the campus of a local community
college. The training meeting with the raters occurred in my home. The fifth phase, IAC
brief opportunistic intervention implementation simulation, took place in offices in the
nursing department of a community college arranged to simulate the physical
environment found in primary care prenatal clinics. The final and sixth phase, during
which the raters independently audited and scored the audio recordings, occurred in the
raters’ homes. The weekly meetings with the raters took place in my home.
Sample
Six participants comprised the convenience sample for this study. I recruited
participants from among frontline office staff members employed by the county’s
community health center prenatal clinics or local private obstetrician offices. Inclusion
criteria for the study were: (a) trained to implement the IAC brief opportunistic
intervention according to prenatal clinic policy, (b) a minimum of 2 years experience in
IAC implementation, (c) English-speaking, and (d) adequate hearing and vision to
conduct an interview. No other criteria were used for inclusion in the study.
Sample size. The statistical sample for this study was the total number of IAC
brief opportunistic intervention sessions implemented by the participants. The number of
sessions determined as adequate for this study was based on calculation of the required
sample size for inter-rater reliability, measured using the intra-class correlation
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coefficient (ICC) (Walter, Eliasziw, & Donner, 1998). The key determinants of sample
size in this calculation are: (a) the level of acceptable inter-rater agreement; (b) the level
of anticipated inter-rater agreement, and (c) the difference between these two values
(Walter et al., 1998). I used guidelines for differentiating ICC estimates of inter-rater
reliability that are clinically meaningful from those that are not (Cicchetti, 1994; Landis
& Koch, 1977). When the ICC is calculated to estimate levels of inter-rater agreement,
guidelines recommend the following criteria for determining clinical significance: below
0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74 is good; and 0.75 to 1.00 is excellent
(Cicchetti; Cicchetti & Sparrow, 1981). For my study, I judged 0.70 to be the minimum
level of acceptable inter-rater agreement, a value generally recognized as satisfactory
(Nunnally & Bernstein, 1994). I anticipated that inter-rater agreement would be 0.85
because higher levels are reasonably attained when strategies to achieve and maintain
inter-rater reliability are implemented, including: comprehensive rater training, initial
calibration through achievement of consensus on practice ratings, and regular
recalibration meetings (Barber & Crits-Christoph, 1996; Hill, O'Grady, & Elkin, 1992;
Perepletchikova et al., 2007; Tevyaw & Monti, 2004).
In accordance with these values, a sample size of 49 interviews was required to
achieve 0.90 power with an alpha of 0.05 for a one-sided significance test, when
acceptable inter-rater agreement is 0.70, anticipated inter-rater agreement is 0.85, and
three raters are used. Each of the six participants recruited for the study were scheduled to
conduct simulated interviews with each of the nine standardized patients, which would
have resulted in 54 cases. This number was reduced by circumstances that occurred
during this phase of the study including a personal conflict that prevented one of the
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participants returning to conduct scheduled interviews with three of the standardized
patients, and two audio recordings that were unintelligible. As a result, the precise
minimum required sample size of 49 cases was achieved.
Participant recruitment. I mailed introductory letters describing the study to
provider and frontline staff employed by the prenatal offices and clinics within the county
(Appendix K). The following week, I contacted these agencies by telephone and spoke
directly with frontline staff members whose job responsibilities included IAC brief
opportunistic intervention. During these conversations, I introduced myself, answered
questions about the study, and invited the staff members to contact me directly if they
thought they might want to participate. Of the 10 individuals who subsequently contacted
me to express interest, 6 eventually participated in the study. One interested frontline
staff member did not meet the inclusion criteria, having had insufficient experience
conducting the IAC intervention. Three other individuals who did meet the screening
criteria had schedules that proved to be too demanding to accommodate study
participation. Participants were compensated for their participation at an hourly rate
commensurate with their normal employment.
Procedures for Protection of Human Participants
I sought approval for the study protocol from the Duquesne University
Institutional Review Board. I obtained informed consent (Appendix M) from each of the
frontline staff participants during their initial meeting with me. I informed participants
that their involvement was totally voluntary and that there were no consequences for nonparticipation. There were no anticipated risks to participation and anticipated benefits
included the dissemination of study findings to a larger health care audience. Consents
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were not required of the therapist, the standardized patients, or the raters, because these
individuals were employees rather than participants. Each rater signed a confidentiality
statement (Appendix N). I used the following measures to protect the confidentiality and
rights of the participants:
1. All study documents were kept confidential and free from participant
identifiers. I assigned each participant a pseudonym that I used in analyzing
the information that was obtained. Only I knew the matching names and the
corresponding pseudonyms. The original list containing participant contact
information and pseudonym cross-referencing was kept in a locked file
cabinet in my home office throughout the duration of the study and will be
destroyed when the results have been published.
2. I listened to the audio recordings to ensure that there were no referents that
could have potentially identified the participants before the audio recordings
were given to the raters. I labeled each audio recording with the specific
participant’s pseudonym. Compact discs containing audio recordings were
kept in a locked file cabinet in my home office except when they were issued
to the raters. The computer containing the digital audio recording files of the
clinic simulations is situated in my home office and is not accessible by any
individuals other than myself. I set a master password, known only to me, for
this computer. All study materials will be destroyed at the end of the study
with the exception of the de-identified files of the digital audio recordings and
the de-identified database.
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Procedures for Data Collection
I collected content validity evidence in conjunction with tool development and
content expert judgment during phase one of the study. The remaining data comprised
treatment fidelity scores assigned by the three raters.
Data collection instrument. During the first phase of the study, I developed the
IAC treatment fidelity instrument that was used to collect research data. This instrument
guided measurement of the adherence and competence behaviors associated with
implementation of the IAC brief opportunistic intervention by the participants. I used a
demographic tool to collect data describing age, gender, race, level of education, and
years of experience of the participants (Appendix L).
Data analysis. I used the PASW Grad Pack 18.0 for Mac (formerly SPSS) to
analyze descriptive and psychometric data. An assistant professor in the department of
statistics from a state university provided professional statistical consultation.
Content validity. I. J. Chasnoff and R. F. McGourty, co-developers of the IAC
brief opportunistic intervention, served as content experts for this study and conducted
the content validity analysis described earlier (see research protocol phase I, steps 5 and
6). I used the clarity and sufficiency ratings assigned by the content experts to compute a
content validity index (CVI) quantifying their extent of agreement. The CVI was
computed by dividing the number of items rated as 4 for clarity (item is clear) and
sufficiency (item is sufficient), by the total number of items on the instrument (Polit &
Hungler, 1999; C. F. Waltz et al., 2005). Although a CVI of 0.80 or greater is generally
considered acceptable (Davis, 1992), Lynn (1986) proposed that when content validity is
assessed with fewer than six experts, perfect agreement should exist. Accordingly, I
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continued the process of instrument revisions until I achieved a CVI of 1.0 for all scale
items.
Inter-rater reliability. Inter-rater reliability is an estimate of the extent to which
raters obtain the same result when independently using an instrument to measure an
observation (Polit & Hungler, 1999). This form of reliability measures the proportion of
variance in a set of ratings in relation to the total variance of the ratings (James, Demaree,
& Wolf, 1984). The ICC allows assessment of rating reliability through a comparison of
the variability of different ratings for a data set and is the statistic of choice for measuring
levels of agreement between a consistent set of raters (Shrout & Fleiss, 1979). In
addition, the ICC is the appropriate measure of inter-rater reliability with dimensionally
scaled data (such as Likert-type scaling) and when more than two raters are used
(Cicchetti, 1994). As stated earlier, the clinical significance of a given ICC value is
interpreted as: below 0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74 is good; and 0.75 to
1.00 is excellent (Cicchetti; Cicchetti & Sparrow, 1981). I calculated the ICC as an index
of the agreement between the adherence and competence scores assigned by the
independent raters. Detailed findings regarding the inter-rater reliability results associated
with use of the IAC treatment fidelity instrument are presented in chapter 4.
Internal consistency reliability. Internal consistency reliability measures the
extent of correlation between different items on an instrument that have been designed to
measure the same construct (Polit & Hungler, 1999). Coefficient alpha is the most
frequently used index of internal consistency (DeVon et al., 2007). An alpha coefficient
of 0.70 is considered acceptable for a new scale (DeVellis, 2003); coefficients of 0.80 or
higher are desirable for established scales (Nunnally & Bernstein, 1994). I calculated this
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statistic for the combined adherence and competence ratings of the three raters to provide
an estimate of the degree of interrelatedness associated with the IAC treatment fidelity
instrument. Details of the internal consistency reliability findings are presented in chapter
four.
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Chapter 4
Results and Discussion
This chapter includes the findings of this study to develop the IAC treatment
fidelity instrument and evaluate the psychometric characteristics associated with its use. I
present a demographic profile of the study participants and describe the results and
analyses associated with the research questions that address the validity and the reliability
associated with the instrument. This chapter concludes with a discussion of the findings.
Recruitment of Study Participants
After receiving approval for this study from the Duquesne University Institutional
Review Board, I secured a convenience sample of 6 frontline prenatal office staff
members as previously described. The phase of the study protocol during which
participants conducted interviews and implemented the IAC brief intervention with the
standardized patients in a simulated prenatal clinic setting took place over a 3-week
period in June 2010. Data collection occurred over a 5-week period in June and July
2010. During this phase, the raters used the IAC treatment fidelity instrument to assign
scores that reflected their assessment of the fidelity with which participants implemented
the IAC brief opportunistic intervention during the simulated clinics.
Characteristics of Study Participants
Demographic data for the sample are summarized in Table 1. The frontline staff
participants in this study were female, ranging in age from 32 to 52 years. In terms of
race, half described themselves as Hispanic/Latino and the rest as non-Hispanic White.
Three of the participants reported high school as their highest level of education attained;
the remaining three participants held an associate degree, bachelor’s degree in health
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science, and master’s degree in nursing. The composition of work positions held by the
participants were 50% (n =3) medical assistant, 33% (n=2) perinatal educator, and 17%
(n=1) nurse practitioner, reflecting the staffing structure found in primary care practice
(Grumbach & Bodenheimer, 2004). In terms of prenatal primary care employment
experience, participants reported 3 to 6 years (n=3), 7 to10 years (n=2), and over 10 years
(n=1). Participants reported that they had been implementing the IAC brief intervention
in their practices for 2 to 4 years (n=3), 5 to 7 years (n=1) and more than 7 years (n=2).
Table 1
Demographic Descriptions of Participants (N = 6)
Category

n

Age
32 to 42
43 to 52

3
3

Female

6

Gender
Race
Non-Hispanic White
Hispanic/Latino
Highest Level of Education
High School
Associate Degree
Bachelor’s Degree Health Science
Master’s Degree Nursing
Work Position
Medical Assistant
Perinatal Educator
Nurse Practitioner
Years Worked in Prenatal Clinical or Office
3 to 6
7 to 10
More than 10
Years Implementing IAC
2 to 4
5 to 7
More than 7

3
3
3
1
1
1
3
2
1
3
2
1
3
1
2
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Analysis of Research Questions
Research question 1: “What is the content validity associated with an instrument
developed to assess treatment fidelity in the delivery of a brief opportunistic intervention
to decrease the use of alcohol, tobacco, and other drugs by pregnant women?”
I conducted a content validity assessment to determine the degree to which the
items included in the instrument adequately represented the fundamental concepts and
behaviors associated with implementation of the IAC brief opportunistic intervention. I
assessed content validity with the assistance of content experts I. J. Chasnoff and R. F.
McGourty, who co-developed the IAC brief opportunistic intervention. I submitted each
draft of the IAC treatment fidelity instrument for their recursive review until a final CVI
of 1.0 reflected their complete accord regarding the clarity, sufficiency, and relevance of
the scale items. The fourth and final version fulfilled this requirement and was the edition
used by the raters during data collection (Appendix F).
Reliability test assumptions. The fulfillment of assumptions underlying the
statistical tests chosen to analyze study data should be considered when evaluating the
cogency of the statistical conclusions (Sheskin, 2003). I selected Cronbach’s alpha
coefficient and the ICC the to assess the reliability of the ratings that were assigned by
the raters using the IAC treatment fidelity instrument. The primary assumptions of these
parametric tests are that sample data will be distributed normally and will display
variance comparable to the population to which the findings are generalized (Munro,
1997). In this study, there was a notable lack of variance among the scores assigned by
the raters, resulting in an asymmetrical, negatively skewed distribution of data with the
scores clustered toward the positive end of the scale. Because the ratings in this study
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varied so little, there was no mechanism that could be applied to transform scale data in
order to introduce variability and approximate the normal distribution necessary to meet
the parametric assumptions underlying these tests (Cicchetti & Feinstein, 1990; Sheskin,
2003). When study data fail to meet the equal variance and normality assumptions
required of parametric tests, use of nonparametric tests (that typically do not rely on
assumptions of normal distribution of the variable in the population) should be
considered (Sheskin, 2003). The Kuder-Richardson formulas (KR 20 and KR 21), which
are the nonparametric measures of internal consistency analogous to Cronbach’s alpha,
are only suitable for measures with dichotomous variables (Allen & Yen, 2002),
rendering these tests unsuitable for this study. Weighted kappa, the ICC’s nonparametric
equivalent, is mathematically identical to the ICC (Norman & Streiner, 2008) and is
equally sensitive to the effects of uneven data distribution (Feinstein & Cicchetti, 1990).
Accordingly, I used Cronbach’s alpha and the ICC in the reliability analyses as specified
in the study protocol. These parametric tests are consistent with the statistical approaches
that have been described and recommended for use when developing a measure of
treatment fidelity (Stein et al., 2007).
Research question 2: “What is the inter-rater reliability associated with use of an
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic
intervention to decrease the use of alcohol, tobacco and other drugs by pregnant
women?”
Inter-rater reliability describes the extent of agreement among the scores assigned
by a group of raters assessing the same behaviors (James et al., 1984). The ICC measures
the consistency of the relative rankings of scores among raters (Shrout & Fleiss, 1979)
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and is contingent on the relationships among the ratings rather than relying on raters
assigning the same scores. ICCs (followed by the 95% confidence interval bounds)
calculated as indices of the reliability of the adherence and competence subscales in
addition to each scale item are presented in Table 2. If these calculations were to be
repeated with multiple samples, the computed confidence intervals are expected to
encompass the true ICC population value 95% of the time (Munro, 1997).
Table 2
IAC Treatment Fidelity Instrument Inter-rater Reliability (N = 49)
ICCa

Scale Items
Adherence subscale (10 items)
Competence subscale (8 items)

0.64
0.62

95% Confidence Interval
Lower
Upper
0.42
0.39

0.78
0.77

1: Bridging comment – adherence
0.44
0.10
0.66
2: Bridging comment – competence
0.56
0.29
0.74
3: “I” message – adherence
0.21
0.00
0.53
4: “I” message – competence
0.15
-0.36
0.49
5: Attempts to share information – adherence
(0.00)
6: Attempts to share information - competence
0.51
0.22
0.71
7: Conveys awareness of willingness - competence
0.74
0.59
0.85
8: Explains effects of substance use - adherence
0.60
0.35
0.76
9: Explains effects of substance use - competence
0.80
0.67
0.88
10: Advocates drug abstinence – adherence
0.65
0.43
0.79
11: Advocates drug abstinence – competence
0.77
0.63
0.86
12: Provides openings to react – adherence
0.20
0.00
0.52
13: Responds to woman’s reaction – adherence
(-0.07)
14: Responds to woman’s reaction - competence
0.46
0.13
0.68
15: Acknowledges decision to discuss drugs - adherence
0.61
0.37
0.77
16: Offers referrals – adherence
0.81
0.69
0.89
17: Offers referrals – competence
0.80
0.67
0.88
18: Refers medical questions – adherence
0.70
0.52
0.82
Note. Values enclosed in parentheses represent paradoxically low ICC calculations. Dashes indicate that
confidence intervals were not estimated.
a
ICC = intraclass correlation coefficient

Guidelines developed by Cicchetti and Sparrow (1981) to examine levels of interrater agreement stipulate that an ICC below 0.40 is poor; 0.40 to 0.59 is fair; 0.60 to 0.74
is good, and 0.75 to 1.00 is excellent. Accordingly, the ICC values attained for the
adherence (0.64) and competence (0.62) subscales correspond to a satisfactory level of
inter-rater reliability.
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The ICCs calculated for the individual items vary widely, ranging from -0.07 to
0.81. Ostensibly, the values at the lower end of the range would seem to indicate poor
inter-rater reliability. To adequately calculate inter-rater reliability, ratings should be
distributed across the breadth of the scale (C. F. Waltz et al., 2005). There is a wellknown limitation associated with the ICC (which corresponds to the weighted kappa
measured on an ordinal scale; Fleiss & Cohen, 1973) and other reliability test statistics
described as the kappa “base rate problem” (Feinstein & Cicchetti, 1990). This problem
occurs in the presence of data prevalence, when a high proportion of ratings fall under
only a few of the scale scores (Hoehler, 2000). The paradoxical effects associated with
data prevalence arise “when the overall proportion of positive results is substantially
different from 50%” (Hoehler, 2000, p. 500). In this event, the amount of agreement that
can be expected to occur by chance alone is increased and the size of the correlation
coefficient correspondingly declines.
When low ICC scores are computed from high-prevalence measurement data, it is
appropriate to additionally report the percentage of actual rater agreement as a further
indicator of inter-rater reliability (Hoehler, 2000). Table 3 displays the observed
percentage-agreement among the raters for each scale item accompanied by the obtained
ICC for comparison. Overall, the high level of rater agreement is illustrated by the fact
that, for all of the scale items, the incidence of no agreement among raters occurred no
more that 6% of the time. The base rate problem is exemplified in item 5, which showed
an ICC of 0.00 although the raters were in complete agreement 98% of the time. All of
the low-ICC adherence items (3, 5, 12, and 13) are associated with levels of complete
rater agreement of at least 86%. Complete rater agreement for item 4 (the sole
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competence item showing a low ICC) is 55%. This does not differ significantly from the
levels of complete rater agreement observed for other competence components, which
range from 47% to 65%.
Table 3
IAC Treatment Fidelity Instrument Rater Agreement Percentage (N = 49)
Rater Agreement
None
Two
Three

Scale Item

ICC

1: Bridging comment – adherence
0.02
0.27
0.71
0.44
2: Bridging comment – competence
0.06
0.43
0.51
0.56
3: “I” message – adherence
0.00
0.14
0.86
0.21
4: “I” message – competence
0.04
0.41
0.55
0.15
5: Attempts to share information – adherence
0.00
0.02
0.98
0.00
6: Attempts to share information - competence
0.04
0.33
0.63
0.51
7: Conveys awareness of willingness - competence
0.06
0.41
0.53
0.74
8: Explains effects of substance use - adherence
0.00
0.20
0.80
0.60
9: Explains effects of substance use - competence
0.06
0.41
0.53
0.80
10: Advocates drug abstinence – adherence
0.00
0.16
0.84
0.65
11: Advocates drug abstinence – competence
0.02
0.51
0.47
0.77
12: Provides openings to react – adherence
0.02
0.10
0.88
0.20
13: Responds to woman’s reaction – adherence
0.00
0.10
0.90
-0.07
14: Responds to woman’s reaction - competence
0.06
0.33
0.61
0.46
15: Acknowledges decision to discuss drugs - adherence
0.00
0.33
0.67
0.61
16: Offers referrals – adherence
0.00
0.10
0.90
0.81
17: Offers referrals – competence
0.02
0.33
0.65
0.80
18: Refers medical questions – adherence
0.00
0.12
0.88
0.70
Note: Rater agreement values reflects the number of scores when raters were in agreement as a percent of
the total possible scores (N = 49 for each scale item; None = no raters were in agreement; ICC = intraclass
correlation coefficient; ICC values less than .40 are shown in boldface.

It is clear from direct appraisal of the values displayed in Table 3 that the rater
agreement percentages alone cannot completely account for the paradoxical ICC results.
For example, the ICC associated with item 13 is even lower at -0.07 than that obtained
for item 5, although raters were in complete agreement less often for that item. It is also
apparent that the high levels of agreement attained in items 16 and 18 did not produce
contradictorily low ICCs.
Further analysis of the effect of high prevalence on the inter-rater reliability
statistic can be evaluated through the direct examination of the raters’ scores. The rating
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frequency of adherence and competence components among the raters is presented in
Tables 4 and 5. Adherence items were rated on a 3-point scale, and competence items
were measured on a 5-point scale.
Table 4
IAC Treatment Fidelity Instrument Adherence Items Rating Frequency (N = 49)
Scale Item

Rater

Adherence Scale Ratings
Disagree Undecided
Agree

N/A

Mean

SD

One
10
3
36
2.53
0.82
1: Bridging comment Two
2
0
46
2.92
0.40
Three
2
3
44
2.86
0.46
One
3
0
46
2.88
0.48
3: “I” message
Two
1
0
48
2.96
0.29
Three
4
0
45
2.84
0.55
One
0
1
48
2.98
0.14
5: Attempts to share
Two
0
0
49
3.00
0.00
information
Three
0
0
49
3.00
0.00
One
4
0
45
2.84
0.55
8: Explains effects of
Two
1
2
46
2.92
0.34
use
Three
5
3
41
2.73
0.64
One
4
2
43
2.80
0.58
10: Advocates
Two
2
1
46
2.90
0.42
abstinence
Three
3
1
45
2.86
0.50
One
2
1
46
2.90
0.42
12: Provides opening
Two
0
0
49
3.00
0.00
to react
Three
2
2
45
2.88
0.44
One
1
1
47
2.94
0.32
13: Responds to
Two
0
0
49
3.00
0.00
reaction
Three
2
2
45
2.90
0.42
One
7
2
40
2.67
0.72
15: Acknowledges
decision to discuss Two
6
4
39
2.67
0.69
drugs
Three
4
5
40
2.73
0.61
One
4
1
44
2.82
0.57
16: Offers referrals
Two
1
1
47
2.94
0.32
Three
3
1
45
2.86
0.50
One
0
0
1
49
0.06
0.43
18: Refers medical
Two
1
0
6
42
0.39
1.00
a
questions
Three
0
0
2
47
0.12
0.60
Note: Ratings values represent the frequency with which rater one, rater two, and rater three assigned
scores for adherence scale items.
a
Only adherence component with a “not applicable” rating option
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Table 5
IAC Treatment Fidelity Instrument Competence Items Rating Frequency (N = 49)

N/A

Strongly
Agree

Agree

Undecided

Rater

Disagree

Scale Item

Strongly
Disagree

Competence Scale Ratings

Mean

SD

One
0
3
2
10
31
3
3.92
1.70
2: Bridging comment
Two
0
0
0
5
42
2
4.69
1.03
Three
0
0
0
10
36
3
4.45
1.24
One
0
0
0
18
30
1
4.53
0.82
4: “I” message
Two
0
0
0
5
43
1
4.80
0.77
Three
1
0
3
6
38
1
4.57
1.02
One
0
0
0
13
36
0
4.73
0.45
6: Attempts to share
Two
0
0
1
4
44
0
4.88
0.39
information
Three
0
0
1
11
37
0
4.73
0.49
One
0
1
3
12
33
0
4.57
0.71
7: Conveys awareness
Two
0
0
3
9
37
0
4.69
0.59
Three
0
1
2
10
36
0
4.65
0.66
One
0
2
0
12
33
2
4.43
1.16
9: Explains effects of
Two
0
0
0
3
45
1
4.84
0.75
use
Three
0
0
1
3
42
3
4.59
1.24
One
0
0
0
17
31
1
4.55
0.82
11: Advocates
Two
0
0
0
6
41
2
4.67
1.03
abstinence
Three
0
0
0
10
36
3
4.45
1.24
One
0
1
0
10
37
1
4.63
0.89
14: Responds to
Two
0
0
0
1
48
0
4.98
0.14
reaction
Three
0
0
0
10
37
2
4.59
1.04
One
0
0
1
10
33
5
4.22
1.55
17: Offers referrals
Two
0
0
0
1
46
2
4.78
1.01
Three
0
0
1
2
43
3
4.61
1.24
Note: Ratings values represent the frequency with which rater one, rater two and rater three assigned scores
for competence scale items.

It is apparent from the data displayed in Tables 4 and 5 that the preponderance of
ratings is clustered under the positive end of the scale, resulting in a negatively skewed,
sharply peaked distribution. Further evaluation of the prevalence effect can be achieved
by computing the coefficient of variation (CV) associated with the ratings for each scale
item. When the CV associated with a scale item is small, this further corroborates that
ratings fall only under a few of the scale scores. Table 6 displays the mean CV of the
scores assigned by the raters for each scale item, together with the percentage of
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complete rater agreement and the calculated ICC for comparison.
Table 6
IAC Treatment Fidelity Instrument Inter-rater Reliability Results Comparison (N = 49)
Scale Item

CV

Complete
Agreement

ICC

1: Bridging comment - adherence
20.67
0.71
0.44
2: Bridging comment - competence
31
0.51
0.56
3: “I” message - adherence
15.31
0.86
0.21
4: “I” message - competence
18.77
0.55
0.15
5: Attempts to share information - adherence
1.6
0.98
0.00
6: Attempts to share information - competence
9.26
0.63
0.51
7: Conveys awareness of willingness - competence
14.07
0.53
0.74
8: Explains effects of substance use - adherence
18.21
0.80
0.60
9: Explains effects of substance use - competence
22.83
0.53
0.80
10: Advocates drug abstinence - adherence
17.54
0.84
0.65
11: Advocates drug abstinence - competence
22.65
0.47
0.77
12: Provides openings to react - adherence
9.92
0.88
0.20
13: Responds to woman’s reaction - adherence
8.43
0.90
-0.07
14: Responds to woman’s reaction - competence
14.86
0.61
0.46
15: Acknowledges decision to discuss drugs - adherence
24.95
0.67
0.61
16: Offers referrals - adherence
16.1
0.90
0.81
17: Offers referrals - competence
28.18
0.65
0.80
18: Refers medical questions - adherence
490.13
0.88
0.70
Note: CV = coefficient of variation; CV values calculated from mean of raters’ scores for each scale item;
ICC = intraclass correlation coefficient; Complete agreement values reflect percentage when all raters
selected same score; Values for scale items associated with ICCs less than .40 are shown in boldface.

All of the low-ICC adherence items (3, 5, 12, and 13) are associated with
significantly lower CVs and higher levels of complete rater agreement in comparison to
other adherence scale items. As a result, the inter-rater reliability statistics calculated
from these data must be interpreted in light of the low data variance. This pattern is not
replicated in the statistics associated with item 4, which is the only low-ICC competence
item.
Research question 3: “What is the internal consistency associated with use of an
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic
intervention to decrease the use of alcohol, tobacco, and other drugs by pregnant
women?”
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Internal consistency reliability assesses the communality of results across items
within a scale and provides an estimate of the degree to which scale items designed to
reflect the same construct produce similar results (Trochim & Donnelly, 2007). I
evaluated the internal consistency reliability associated with use of the IAC treatment
fidelity instrument using Cronbach’s coefficient alpha. The inter-correlations among
scale items are presented in Table 7.
Table 7
IAC Treatment Fidelity Instrument Internal Consistency Reliability (N = 49)
Scale Items

Number of
Items

Cronbach’s
Alpha

Spearman-Brown
Prophecy r2

All scale items
18
0.72
0.84
Adherence subscale
10
0.54
0.70
Competence subscale
8
0.56
0.72
Note: Spearman-Brown prophecy reflects estimated reliability coefficient if scale were twice as long.

An internal consistency analysis using the ratings obtained for the entire scale
yielded a coefficient of 0.72. While an alpha coefficient above 0.80 is desirable, a
coefficient of 0.70 is considered an acceptable measure of internal consistency reliability
for a new scale in the preliminary stages of development (DeVon et al., 2007). Because
the IAC treatment fidelity instrument was designed to measure the complementary
dimensions of adherence and competence during implementation, I also calculated
Cronbach’s alphas separately for the scores obtained from each subscale. The internal
consistency reliabilities for the adherence and competence subscales were 0.54 and 0.56
respectively.
A factor that directly impacts the measurement of alpha is instrument length; the
greater the number of items included on an instrument, the higher the resulting alpha (C.
F. Waltz et al., 2005). As a result, measures of internal consistency reliability are
increased through the addition of further scale items (DeVellis, 2003). The Spearman76

Brown prophecy formula allows the estimation of instrument reliability at differing
lengths based on the known reliability of the measure (Carmines & Zeller, 1979),
assuming that the additional items retain the nature of the original test (C. F. Waltz et al.,
2005). I used the Spearman-Brown formula to estimate what the reliabilities would be if
the scales were doubled. The coefficients increased to 0.84 for the entire scale, 0.70 for
the adherence subscale, and 0.72 for the competence subscale (see Table 7).
Table 8 presents further analysis of the internal consistency of the instrument
adherence and competence subscales, accomplished by sequentially deleting items from
each of the subscales and computing correlation coefficients for the modified subscale.
Elimination of two items resulted in slightly higher alphas, although neither approached
the requisite 0.70. For the adherence subscale, the deletion of item 18 produced a higher
alpha (0.59), in comparison to that of the unmodified version (0.54). For the competence
subscale, alpha was increased from 0.56 to 0.61 with the omission of item 17.
Table 8
IAC Treatment Fidelity Instrument Internal Consistency: Modified Subscales (N = 49)
Scale

Item Deleted

Adherence subscale

Cronbach’s Alpha

1: Bridging comment
3: “I” message
5: Attempts to share information
8: Explain effects of substance use
10: Advocates drug abstinence
12: Provides openings to react
13: Responds to women’s reaction
15: Acknowledges decision to discuss drugs
16: Offers referrals
18: Refers medical questions
Competence subscale
2: Bridging comment
4: “I” message
6: Attempts to share information
7: Conveys awareness of willingness
9: Explain effects of substance use
11: Advocates drug abstinence
14: Responds to women’s reaction
17: Offers referrals
Note: Values reflect subscale internal consistency with deletion of specified items.
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0.49
0.50
0.54
0.50
0.48
0.49
0.52
0.49
0.54
0.59
0.56
0.48
0.53
0.54
0.46
0.52
0.51
0.61

Discussion of Results
This section presents a discussion of the meaning of the results associated with
the psychometric testing addressed in the research questions that provided the focus for
this study. The conceptual framework that systematically guided both the development of
the IAC treatment fidelity instrument and the measurement process that took place during
this study integrated concepts derived from motivational interviewing and selfdetermination. Both of these theories are based on the fundamental assumption that
individuals are inherently inclined toward positive change (Markland et al.;
Vansteenkiste & Sheldon).
Research question 1: “What is the content validity associated with an instrument
developed to assess treatment fidelity in the delivery of a brief opportunistic intervention
to decrease the use of alcohol, tobacco, and other drugs by pregnant women?”
The evidence that I collected during this study established initial content validity
associated with the IAC treatment fidelity instrument in relation to the content domain of
the IAC treatment fidelity instrument. A CVI of 1.0 reflected the consensus judgment of
two singularly qualified content experts regarding the clarity and quality of the items, the
adequacy with which the items represented the IAC content domain, and the relevance of
the items to the identified construct.
When using this instrument to evaluate IAC implementation, the raters reported
they found it straightforward and inclusive of all of the behavioral elements that required
their assessment. They reported no difficulty making a choice between the three rating
options provided for the adherence items (agree, undecided, disagree), but did question
the need for five levels of agreement for the competence items. The raters stated they
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found it challenging to audibly identify behavioral nuances that allowed them to
distinguish between ratings, such as agree and strongly agree, and they recommended
using a simpler measuring system for competence items, such as the 3-point scale
assigned to the adherence items.
The content validation process that I followed was a two-stage process of
development and judgment recommended by Lynn (1986). The first stage of this process
required me to become conversant with the content domain. To accomplish this, I
conducted a comprehensive appraisal of the relevant literature that I judged to comprise
the content domain, which included motivational interviewing, self-determination theory,
and treatment fidelity, in addition to the IAC brief intervention. This rigorous review
provided me a thorough awareness of the content foundation, upon which I relied as I
developed the individual items that would eventually become the IAC treatment fidelity
instrument. The depth and accuracy of this stage is considered an essential component in
the process of content validation (C. F. Waltz et al., 2005).
Through conducting this study, my understanding of the process of measurement
validity has been strengthened. Validity is a fundamental concept that involves
ascertaining whether an instrument does actually measure the construct it was developed
to measure (C. F. Waltz et al., 2005). When validity is defined thus, it is evident that
construct validity is the unified whole that encompasses all other types of validity
(Goodwin, 2002; C. F. Waltz et al., 2005)}. Content validation is a necessary theoretical
step in tool development as it provides evidence regarding the relationship of the content
domain to the intended interpretation of the scores (Goodwin, 2002). However, content
validity is limited in that the methods used in the assessment of this type of validity do
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not provide actual evidence that the scores obtained through measurement support the
construct (Carmines & Zeller, 1979). Empirical support for the consistency with which an
instrument’s measures represent a content domain can be provided by accumulating
validity evidence based on response processes, internal structure, relationships to other
variables, or the consequences of testing (Goodwin, 2002). This type of validation
assessment is appropriate during the development of a new instrument, as well as for a
fully developed tool. A validity assessment based on evidence derived from test content
alone is insufficient and should be substantiated by evidence collected from validation
activities that allow assessment of the validity of the inferences derived from the scores
obtained through the use of an instrument (Carmines & Zeller, 1979; Goodwin, 2002).
The focus of the first research question that I identified for this study, confined to
the assessment of content validity, was too limited. A more appropriate research question,
acknowledging the broader conceptualization of validity, would have been a more
general inquiry regarding the existence of evidence for validity associated with the
instrument. My assessment of the validity associated with the IAC treatment fidelity
instrument would have been strengthened by designing the study to incorporate methods
that allowed for a wider collection of additional validity evidence.
I have identified a method that could have been incorporated into the design of
this study to provide additional evidence of validity. The contrasted or known groups
approach is a method that can be used to provide evidence based on the empirical
relationship of predictor scores to other variables (Goodwin, 2002). This strategy
involves distinguishing two groups of individuals known to possess contrasting levels of
the attribute the instrument proposes to measure. For this study, I would recruit a second
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group of frontline staff members without any previous IAC experience. This group, in
addition to the experienced frontline staff group, would conduct interviews with the
standardized patients, culminating in IAC brief intervention implementation. If the
treatment fidelity instrument is sensitive to varying levels of IAC implementation
adherence and competence, presumably, the experienced group mean scores would be
higher that than those of the inexperienced group. A significant difference in mean
scores between the groups would imply that the instrument is able to distinguish between
their differing levels of IAC treatment fidelity, the construct that the instrument was
developed to measure. An additional benefit that would be accrued from this
modification to the study design is the heterogeneity it would introduce to the sample.
This might increase the normality of data distribution and the resulting accuracy of the
reliability analyses.
Research question 2: “What is the inter-rater reliability associated with use of an
instrument developed to assess treatment fidelity in the delivery of a brief opportunistic
intervention to decrease the use of alcohol, tobacco, and other drugs by pregnant
women?”
Inter-rater reliability is a psychometric measure that provides an estimate of the
degree of agreement among raters (C. F. Waltz et al., 2005). It is an attribute of the scores
obtained through use of the instrument rather than a property of the instrument itself and
should be assessed with each use of a scale (Guthrie, 2000). The ICCs that I calculated
for the adherence and competence subscales of the IAC treatment fidelity instrument
were acceptable for a new instrument at 0.64 and 0.62 respectively. These findings
provide preliminary support for the use of this instrument to assess treatment fidelity
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during implementation of the IAC brief opportunistic intervention.
The ICCs calculated for 13 of the 18 individual scale items ranged from 0.44 to
0.81; all of these values are within acceptable levels of inter-rater reliability (Cicchetti &
Sparrow, 1981). The ICCs for the remaining scale items (3, 4, 5, 12, and 13), ranging
from -0.7 to 0.21, correspond with less than satisfactory levels of inter-rater reliability.
Respectively, these items were also associated with the highest levels of complete rater
agreement (0.86, 0.98, 0.88, and 0.90) and lowest data variance as evidenced by the CVs
calculated for each item (15.31, 1.6, 9.92, and 8.43). These conditions correspond to
those that have been linked to the base-rate problem, known to generate paradoxically
low inter-rater reliability statistics (Hoehler, 2000). As a result, I conclude that the low
ICCs computed for these items are associated with these factors and fail to accurately
reflect the true levels of inter-rater agreement.
The level of percentage agreement (0.55) and data variance (CV 18.77) associated
with item 4, the remaining low-ICC scale component, did not demonstrate sufficient
magnitude in comparison to other scale items to exert a similar paradoxical influence on
the calculated inter-rater reliability statistic. Consequently, I believe that the ICC
associated with this competence item (which addresses the positive tone of voice
associated with interventionist delivery of the “I” message) is accurate.
During my weekly meetings with the raters, they frequently discussed and sought
clarification on precisely what constituted both an “I” message and a positive tone of
voice. The lack of clarity on this aspect of IAC implementation undoubtedly impacted the
raters’ measurement of the “I” statement adherence statement (item 3) as well as the
paired competence statement (item 4). Measurement of these items were further
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complicated when interventionists used the pronoun “we” instead of “I” in sentences
expressing their concern. When this occurred, raters expressed uncertainty regarding the
authenticity of this statement as an “I” message and were inconsistent in their
measurements of this behavior. Thus, despite the base-rate problem suspected to have
exerted influence on the ICC calculated for item 3 as described above, I suspect that both
item 3 and item 4 would benefit from revision.
When I developed the study protocol, I did not foresee the manner in which the
actions designed to ensure accuracy of implementation of the IAC brief opportunistic
intervention would influence the distribution of data. The frontline staff members that I
recruited for the study were all experienced in conducting the IAC intervention and I
further reviewed and discussed IAC implementation behaviors during my preparatory
meeting with them to ensure consistency of application. As a result, the interventionists
uniformly implemented the IAC brief opportunistic intervention with high fidelity, and
the raters had little opportunity to measure instances of substandard implementation.
Accordingly, the majority of the ratings they assigned were clustered at the positive end
of the scale.
I designed the last three phases my study protocol to occur in successive
increments, with each concluding prior to the subsequent phase. Once the simulated
clinics had taken place and the interviews between the interventionists and the
standardized patients had been recorded, I began to meet with the raters. Each week,
when I met with the raters to discuss their scores, I was encouraged by the significant
agreement that was evident among their ratings. I did not analyze the scores obtained
through the raters’ use of the instrument until the data collection phase involving the
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raters had concluded. As result, I did not recognize the impact that high-fidelity
implementation had exerted on the reliability assessments until my statistical analyses
were completed.
Retrospectively, I have identified alterations to my study protocol that would have
increased sample heterogeneity and minimized the occurrence of paradoxically low
reliability scores. Initially, this issue could have been addressed during the participant
recruitment phase by eliminating the requirement that participants had at least 2 years
experience in IAC implementation, a modification that would have the added benefit of
increasing the number of qualified candidates. However, this presumes that frontline staff
members with less experience would be correspondingly less faithful in their
implementation of the IAC, an assumption that may not be substantiated. To ensure that
the raters have opportunities to measure varying levels of treatment fidelity, I would
ensure that some of the interventionists intentionally implemented the IAC with low
fidelity during their simulated prenatal clinic sessions. This could be accomplished by
using trained actors in addition to actual frontline staff members as interventionists. The
actors could be directed to implement proscribed behaviors and refrain from prescribed
behaviors associated with the IAC intervention. This would guarantee the occurrence of a
range of implementation behaviors, fostering comprehensive use of the instrument’s
scales and a more accurate assessment of the instrument’s reliability.
I have also considered another alteration in the design of my study that could have
enhanced my study findings. During the sixth step in the first phase of my study, a
clinical social work therapist and I independently evaluated, coded, and scored the IAC
implementation behaviors for each of the 9 practice interviews I had conducted and
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recorded earlier when training the standardized patients. I had devised this step to provide
a trial use of the instrument to facilitate content revision. If I had designed this phase as a
small pilot study and had calculated reliability statistics associated with the ratings we
assigned, I might have become aware of the base rate problem before conducting the
simulated clinics and could have redesigned the study protocol at that stage accordingly.
Research question 3: “What is the internal consistency reliability associated with
use of an instrument developed to assess treatment fidelity in the delivery of a brief
opportunistic intervention to decrease the use of alcohol, tobacco, and other drugs by
pregnant women?”
The internal consistency reliability statistic provides an estimate of how well scale
items designed to measure a particular characteristic produce similar results (Trochim &
Donnelly, 2007). I calculated Chronbach’s coefficient alpha to evaluate the internal
consistency of the ratings obtained through the use of the IAC treatment fidelity
instrument during the study. The alpha level for the entire scale items was 0.72,
considered an acceptable measure for a new instrument (DeVon et al., 2007). The internal
consistency reliability estimates for both subscales fell below the acceptable range,
indicating inadequate item intercorrelation.
I found that deleting two items slightly improved the internal consistency of the
subscales. When item 18 was removed, the alpha value of the adherence subscale
increased from 0.54 to 0.59. This item, which was developed to allow measurement of
interventionists’ response when presented with medical questions outside of their scope,
primarily concerns medical assistant practice. As the sole adherence item offering a not
applicable rating option, this item was rated as not applicable in 94% of the cases. In
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retrospect, this item reflects a practice issue that exists independent of IAC
implementation and does not make a meaningful contribution to the assessment of IAC
treatment fidelity.
The alpha of the competence subscale increased from 0.56 to 0.61 with the
deletion of item 16. The intent of this item was to operationalize the desired quality of
interventionist behavior, characterized as “respectful,” when offering referrals. During
rater meetings that took place during data collection, ambiguity regarding the
interpretation of the term “respectful” emerged during the weekly discussions of rating
assignments. Raters expressed that they were uncertain how to identify this behavioral
attribute audibly. This suggests that revision of this item may increase recognition of this
behavior during implementation and improve the internal consistency of the competence
subscale.
The length of the IAC treatment fidelity instrument is also a relevant factor that
requires scrutiny when interpreting the computed internal consistency statistics. The
sturdy relationship between test length and item intercorrelation is illustrated in this study
in that the alpha coefficient computed for the entire 18-item scale, which encompasses
both adherence and competence components, exceeds that of the alpha of either subscale,
which were designed to make these complementary constructs manifest. Ideally, a scale
developed to measure a specific construct will be composed of items measuring attributes
of the construct (Polit & Hungler, 1999), producing a measure of internal consistency that
results from items correlating highly with the designated construct rather than each other
(DeVellis, 2003). According to the statistical corrections I computed using the SpearmanBrown prophecy formula, acceptable reliabilities could be attained by doubling the length
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of the subscales. However, adding redundant items to an instrument for the sole purpose
of inflating alpha may bloat the instrument without adding meaningfully to measurement
of the construct (Kline, 1998). During the scale development phase of this study, several
items that I included in the first draft were perceived as duplicating measures of
behaviors concurrently assessed by other items. Accordingly, these were deleted as per
the recommendations of the content experts. The desired end result was a compact
instrument comprising items designed to reflect operationalization of distinct behaviors
involved in the implementation of the IAC. Consequently, I surmise that the alphas of the
resultant subscales were impacted by their length and may underestimate the true internal
consistency reliability of the scores (Kline, 1998).
Additional factors that have been reported to influence the value of coefficient
alpha should also be considered when interpreting internal consistency reliability results.
Similar to the base-rate paradox described earlier in relation to the ICC, computation of
the alpha coefficient relies on both variance and normal distribution of test scores (C. F.
Waltz et al., 2005). Accordingly, data with a skewed distribution will result in
paradoxically lower alpha values. As previously described, the ratings that arose from
this study display a pattern of high rater agreement and low variance, mitigating factors
that should be taken into consideration when evaluating the statistics calculated from the
ratings of the adherence and competence scale items during this study. As such, it is
difficult to determine whether the low alpha coefficients for these scales accurately
reflected the degree to which the scale items correlated to the intended dimensions.
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Chapter 5
Summary, Conclusions, and Recommendations
This chapter presents a summary and the conclusions of this study, which entailed
the development and psychometric evaluation of a structured instrument to assess the
treatment fidelity of the IAC brief opportunistic intervention designed to reduce prenatal
substance use. Limitations of the study are identified. The chapter concludes with
recommendations for future research and implications for nursing practice.
Summary
The IAC brief opportunistic intervention, designed to reduce prenatal substance
use, is currently implemented by frontline staff (typically registered nurses, licensed
vocational nurses, or medical assistants) in several areas of the United States (Chasnoff et
al., 2008; Children's Research Triangle, 2008). Evaluation of treatment fidelity, to
determine if this and other behavioral interventions are delivered as intended, is essential
to controlled research (Bellg et al., 2004; Dane & Schneider, 1998; Moncher & Prinz,
1991; J. Waltz et al., 1993). The specific aims of this study were to develop an instrument
to measure the treatment fidelity of the IAC brief opportunistic intervention
implementation, and establish the validity and reliability associated with use of the
instrument. The long-term goal of this study is to use this instrument in a randomized
clinical trial assessing the efficacy of the IAC in reducing prenatal ATOD use.
The conceptual framework that guided this study was a blend of concepts derived
from motivational interviewing and self-determination theory. Throughout the process of
instrument development, I drew upon these conceptual frameworks to inform
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operationalization of the IAC behavioral elements that ultimately took shape as the IAC
treatment fidelity instrument.
I conducted this study in six phases. Phase one, tool development, involved
identification of the essential elements involved in implementation of the IAC and
translation of these elements into observable behaviors, selection of appropriate scaling
options, and assessment of content validity. In the second phase, I enlisted nursing
students as standardized patients and prepared them to portray ATOD-using pregnant
women. I recruited and trained nursing instructors as independent raters in the third
phase. During phase four, I recruited experienced frontline prenatal clinic staff members
who were currently implementing the IAC in practice as study participants. In the fifth
phase, the participants implemented the IAC with the standardized patients in a simulated
clinic setting. During the final phase, raters used the instrument developed during the
course of the study to independently assess the treatment fidelity with which the frontline
staff implemented the IAC. To estimate the reliability associated with the scores assigned
by the raters, I used the ICC to calculate inter-rater agreement and Cronbach’s alpha to
measure internal consistency. The study protocol was consistent with methods that have
been identified as essential in the development of a treatment fidelity instrument (Stein et
al., 2007).
Conclusions
The content validity evidence that I collected during the tool development gives
credence to the adequacy with which the IAC treatment fidelity instrument represented
the IAC content domain. The structure of the tool, with paired adherence and competence
components formatted as declarations accompanied by Likert-scaled rating selections,
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was found to be effective.
The inter-rater reliability statistics I calculated for ratings associated with the
instrument subscales and most of the individual scale items were satisfactory, findings
that indicated consistent use of the instrument by the raters during this study (Cicchetti &
Sparrow, 1981). Based on the secondary analysis I conducted to examine the proportion
of rater agreement and prevalence associated with each item, factors known to be
associated with the base-rate problem (Hoehler, 2000), I have concluded that the ICC
values calculated for the low-ICC adherence items (3, 5, 12, and 13) were erroneously
low. Consequently, the inter-rater reliability associated with these items cannot be
adequately assessed through the ratings obtained from this sample.
Because the remaining low-ICC item (4), a component of the competence
subscale, was not conspicuous for either rater agreement or prevalence levels, I conclude
that the ICC calculated for this item is an accurate estimate of inter-rater reliability. This
item and its counterpart (low-ICC item 3) were designed to jointly measure the adherence
and competence with which interventionists express an “I” message. I believe that both of
these items would benefit from revision to increase their clarity.
The Cronbach’s alpha coefficient calculated for the ratings obtained for the entire
instrument, indicated an acceptable level of internal consistency reliability for a new tool
(DeVon et al., 2007). The significance of this finding is attenuated by the fact that the
alpha coefficients for the adherence and competence subscales were low. However, the
blunting influence of high prevalence and low variance of the measurements must also be
taken into consideration when evaluating the implications of the alpha levels (C. F. Waltz
et al., 2005). Until this instrument is used to measure ratings obtained with a more
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heterogeneous sample, enabling a more normal distribution of scores, the question of
whether internal consistency reliability will improve through item revision remains
uncertain. The exception I would make to this conclusion is associated with the findings
discussed earlier in relation to the alphas calculated with the sequential deletion of ratings
associated with each item. When item ratings associated with items 16 and 18 were
removed from the study data, this did afford a modest increase in the alphas calculated
for each subscale. Based on my analysis, I recommend revising item 16 and removing
item 18 to enhance subscale internal consistency reliability results.
Limitations of the Study
The primary limitation of this study was my protocol, which used only
experienced interventionists to implement the IAC in a simulated clinic setting. This
contributed to the consistently high level of treatment fidelity and resulting uniformity of
ratings that characterized this study’s data and influenced the reliability analyses.
Because the interventionists were so dependable in their implementation of the IAC, the
raters had little opportunity to witness instances when implementation occurred with low
fidelity. Thus all of the ratings were clustered under the positive scale scores. This tool
development study would have been impractical to conduct in an actual treatment setting.
In addition to the challenge of recruiting and consenting a sufficient group of participants,
obtaining the necessary sample size of 49 audio-recorded instances of IAC
implementation would have taken an inordinate amount of time to achieve, because most
prenatal interviews do not involve the disclosure of prenatal ATOD use. In a clinical
setting, increased test score variance could be anticipated, but not guaranteed.
Implementation by a pool of experienced interventionists could produce data distribution
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similar to that present in this study that resulted in undependable reliability findings.
Another potential limitation was related to sample size. The calculation of desired
sample size required an assumption about the anticipated level of inter-rater agreement
that would be achieved. Thus, a sample size of 49 was the number required to reject the
implied null hypothesis (the inter-rater agreement is 0.70) versus the implied alternative
hypothesis (the inter-rater agreement is greater than 0.70 with power 0.90, alpha 0.05,
and anticipated agreement 0.85). Consequently, this sample size would be large enough
to reject the null hypothesis 90% of the time when the observed difference between the
null value and the anticipated value was 0.15 (0.85 minus 0.70). After data collection had
concluded and the statistical analysis was complete, it became evident that my a priori
assumption regarding the anticipated level of inter-rater agreement was not substantiated,
because none of the observed ICCs calculated for the subscales or the individual items
approached 0.85. Questioning whether increasing the number of participants would have
had an appreciable impact on the ICCs, I concluded that it was sample homogeneity,
rather than sample size, that was the issue. When the high proportion of rater agreements
are taken into consideration in tandem with the observed ICCs, this supports the
probability that these were paradoxical results that can be attributed to the prevalence
effect (Hoehler, 2000).
Recommendations for Future Research
The results of this study support ongoing evaluation of the IAC treatment fidelity
instrument. Before this instrument can be relied upon as a measure of IAC treatment
fidelity, it must be subjected to revision and further psychometric testing to gather
empirical evidence of validity and reliability associated with the instruments measures.
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Further development of the instrument should involve study in a simulated setting using a
known contrasted groups design, one group with IAC experience and one without. This
method will allow assessment of construct validity through an analysis of the extent to
which the instrument’s measurement is able to distinguish the two groups. This important
psychometric step is needed to establish the treatment fidelity linkage between the
instrument’s measurement and the theoretical constructs that underpin implementation of
the IAC intervention before the tool is tested in an actual clinical setting.
The outcomes of future reliability testing will depend on obtaining heterogeneous
samples and normally distributed data to minimize the occurrence of paradoxically low
reliability scores. This could be accomplished by instructing some interventionists to
deliberately implement the IAC with low fidelity. Based on the findings of these further
validity and reliability analyses, the instrument items should be reviewed to determine if
they adequately represent and measure the IAC content domain.
I encourage researchers who take on the challenge of instrument development to
embrace a wider view of validity and design their research questions accordingly. The
process involved in the assessment of content validity is meaningful and essential to the
development of an instrument designed to reflect a specific content domain. However,
content validity alone does not offer the necessary precision needed to serve as a
benchmark of the validity of the instrument’s measurements. Determination of the degree
to which an instrument actually measures in accordance with theoretically derived
expectations requires using results obtained from the tool to make judgments about
validity. Doing so will allow valid inferences to be made regarding the consequences of
the use of an instrument.
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Implications for Nursing Practice
A goal of nursing research is the discovery of stable relationships that can be used
to improve the human condition (M. E. Rogers, 1970). This study was a first step in the
development of an instrument to measure the treatment fidelity of the IAC brief
opportunistic intervention, which was designed to reduce the prenatal use of potentially
harmful substances. This tool requires further refinement and psychometric testing before
it can be used in the clinical setting. Therefore, there are no specific nursing practice
implications at this time.
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Appendix A
Content Validity Review Request
Antonia Torrey RN, MSN
8315 Portola Road
Atascadero, CA 93422
805 769-6705
torreya@duq.edu
February 14, 2010
Dear Dr. McGourty and Dr. Chasnoff:
Thank you again for agreeing to review the “I Am Concerned” (IAC) Fidelity Instrument
and providing feedback related to its content validity. My intent is to provide an
instrument that accurately reflects the dimensions of the IAC and can be used to assess
the faithfulness of its implementation. Guided by a conceptual framework derived from
motivational interviewing and self-determination theory, I designed this instrument to
measure both the adherence and competence components associated with IAC
implementation and believe the result to be consistent with the complexity and
assumptions underlying the IAC.
I am sending you two documents. One is a first draft of the actual instrument that will be
used by raters to assess the faithfulness of IAC implementation. This will allow you to
see the manner in which I have formatted items with their associated Likert-scaled
responses. In addition, I am sending you a content review questionnaire, which will allow
you to rate each item in terms of its clarity, sufficiency, and relevance; I have also
included an area to insert optional comments. Your respective ratings will allow me to
compute a content validity index. I will continue to revise the instrument in accordance
with your ratings until perfect agreement has been achieved.
Please let me know if you have any questions. I welcome any and all feedback and look
forward to your review.
Sincerely,
Toni Torrey
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Appendix B
Content Review Questionnaire
Reviewer: ______________________
Please rate each item’s clarity, sufficiency, and relevance and comment as needed.
Item
1. To what extent did
the interventionist
use a bridging
comment when
indicated to move the
conversation from
interview to pretreatment?
ADHERENCE

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
2. To what extent did
the interventionist
use an encouraging
tone of voice when
verbalizing bridging
comments?
COMPETENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
3. To what extent did
the interventionist
use an “I” message
when indicated?
ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1

2

3

4
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1

2

3

4

1

2

Item
4. To what extent did
the interventionist
use a positive tone of
voice when
verbalizing “I”
messages?
COMPETENCE

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
5. To what extent did
the interventionist
attempt to share
information
regarding the effects
of prenatal substance
use? ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
6. To what extent did
the interventionist
use a supportive,
warm approach when
attempting to share
information
regarding the effects
of prenatal substance
use? COMPETENCE
Comment:

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient
1

2

3

4
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1

2

3

4

1

2

Item
7. To what extent did
the interventionist
convey awareness of
the woman’s
willingness to hear
information
regarding the effects
of prenatal substance
use? ADHERENCE
Comment:

Clarity

Item

3

4

1

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Item

ADHERENCE

2
Clarity

1

9. To what extent did
the interventionist
provide feedback?

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient
1

8. To what extent did
the interventionist
respectfully convey
awareness of the
woman’s willingness
to hear information
regarding the effects
of prenatal substance
use? COMPETENCE
Comment:

Sufficiency

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1

2

3

4
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1

2

3

4

1

2

Item
10. To what extent
did the
interventionist use a
supportive tone of
voice when
providing feedback?
COMPETENCE

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
11. To what extent
did the
interventionist
explain the effects
that prenatal
substance use can
have on the mother,
baby, and child?
ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
12. To what extent
did the
interventionist use a
nonjudgmental
approach when
explaining the effects
that prenatal
substance use can
have on the mother,
baby, and child?

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

COMPETENCE

Comment:
1

2

3

4
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1

2

3

4

1

2

Item
13. To what extent
did the
interventionist
describe the potential
negative
consequences of the
woman’s substance
use? ADHERENCE

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
14. To what extent
did the
interventionist
convey empathic
sensitivity through
words and tone of
voice when
describing the
potential negative
consequences of the
woman’s substance
use? COMPETENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
15. To what extent
did the
interventionist
advocate a goal of
abstinence rather
than reduction of
drug use?
ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1

2

3

4
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1

2

3

4

1

2

Item
16. To what extent
did the
interventionist use a
supportive tone of
voice when
advocating
abstinence rather
than reduction of
drug use?

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

COMPETENCE

Comment:
1
Item
17. To what extent
did the
interventionist
acknowledge the
woman’s autonomy
and personal choice?
ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
18. To what extent
did the
interventionist
respectfully
acknowledge the
woman’s autonomy
and personal choice?
COMPETENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1

2

3

4
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1

2

3

4

1

2

Item
19. To what extent
did the
interventionist
convey that the
discussion was a
collaborative
interaction in
contrast to one where
the interventionist is
in charge?

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

ADHERENCE

Comment:

1

Item
20. To what extent
did the
interventionist use a
supportive approach
when conveying that
the discussion was a
collaborative
interaction in
contrast to one where
the interventionist is
in charge?

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

COMPETENCE

Comment:

1

Item
21. To what extent
did the
interventionist
emphasize the
greater importance of
the woman’s own
decisions,
confidence, and
perception of the
importance of
changing?

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

ADHERENCE

Comment:

1

2

3

4
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1

2

3

4

1

2

Item
22. To what extent
did the
interventionist
convey empathic
sensitivity when
emphasizing the
greater importance of
the woman’s own
decisions,
confidence, and
perception of the
importance of
changing.

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

COMPETENCE

Comment:
1
Item
23. To what extent
did the
interventionist
acknowledge the
woman’s decision to
discuss her drug use?
ADHERENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item

2

3

4

Clarity

1

2

3

Sufficiency

4

1

2

Relevance

24. To what extent
1. Item is not clear 1. Item is not
1. Item is not
did the
2. Item needs
sufficient
relevant and
interventionist
major revision
2. Item needs
should be
verbalize praise when
to be clear
major revision to
deleted
acknowledging the
3. Item needs
be sufficient
2. Item is relevant
woman’s decision to
minor revision
3. Item needs
and should be
discuss her drug use?
to be clear
minor revision
retained
COMPETENCE
4. Item is clear
to be sufficient
4. Item is sufficient
Comment:
1
2
3 4
1
2
3 4
1
2
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Item
25. To what extent
did the
interventionist offer
indicated referrals?
ADHERENCE

Clarity

Sufficiency

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1
Item
26. To what extent
did the
interventionist
respectfully offer
indicated referrals?
COMPETENCE

2

3

4

1

Clarity

2

3

4

Sufficiency

1

2

Relevance

1. Item is not clear 1. Item is not
1. Item is not
2. Item needs
sufficient
relevant and
major revision
2. Item needs
should be
to be clear
major revision to
deleted
3. Item needs
be sufficient
2. Item is relevant
minor revision
3. Item needs
and should be
to be clear
minor revision
retained
4. Item is clear
to be sufficient
4. Item is sufficient

Comment:
1

2

3

4
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1

2

3

4

1

2

Appendix C
IAC TREATMENT FIDELITY INSTRUMENT – Draft 1
1. To what extent did the interventionist use a bridging comment when indicated to move
the conversation from interview to pre-treatment?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
2. To what extent did the interventionist use an encouraging tone of voice when
verbalizing bridging comments?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
3. To what extent did the interventionist use an “I” message when indicated?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
4. To what extent did the interventionist use a positive tone of voice when verbalizing “I”
messages?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
5. To what extent did the interventionist attempt to share information regarding the
effects of prenatal substance use?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
6. To what extent did the interventionist use a supportive, warm approach when
attempting to share information regarding the effects of prenatal substance use?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
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7. To what extent did the interventionist convey awareness of the woman’s willingness to
hear information regarding the effects of prenatal substance use?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
8. To what extent did the interventionist respectfully convey awareness of the woman’s
willingness to hear information regarding the effects of prenatal substance use?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
9. To what extent did the interventionist provide feedback?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
10. To what extent did the interventionist use a supportive tone of voice when providing
feedback?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
11. To what extent did the interventionist explain the effects that prenatal substance use
can have on the mother, baby, and child?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
12. To what extent did the interventionist use a nonjudgmental approach when explaining
the effects that prenatal substance use can have on the mother, baby, and child?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
13. To what extent did the interventionist describe the potential negative consequences of
the woman’s substance use?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
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14. To what extent did the interventionist convey empathic sensitivity through words and
tone of voice when describing the potential negative consequences of the woman’s
substance use?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
15. To what extent did the interventionist advocate a goal of abstinence rather than
reduction of drug use?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
16. To what extent did the interventionist use a supportive tone of voice when advocating
abstinence rather than reduction of drug use?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
17. To what extent did the interventionist acknowledge the woman’s autonomy and
personal choice?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
18. To what extent did the interventionist respectfully acknowledge the woman’s
autonomy and personal choice?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
19. To what extent did the interventionist convey that the discussion was a collaborative
interaction in contrast to one where the interventionist is in charge?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
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20. To what extent did the interventionist use a supportive approach when conveying that
the discussion was a collaborative interaction in contrast to one where the interventionist
is in charge?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
21. To what extent did the interventionist emphasize the greater importance of the
woman’s own decisions, confidence, and perception of the importance of changing?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
22. To what extent did the interventionist convey empathic sensitivity when emphasizing
the greater importance of the woman’s own decisions, confidence, and perception of the
importance of changing.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
23. To what extent did the interventionist acknowledge the woman’s decision to discuss
her drug use?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
24. To what extent did the interventionist verbalize praise when acknowledging the
woman’s decision to discuss her drug use?
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
25. To what extent did the interventionist offer indicated referrals to the woman?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
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26. To what extent did the interventionist respectfully offer indicated referrals to the
woman?
ADHERENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Not at all
A Little
Somewhat
Quite a Bit
Extensively
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Appendix D
IAC TREATMENT FIDELITY INSTRUMENT – Draft 2
1. The interventionist uses a bridging comment when indicated to move the conversation
from interview to pre-treatment.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree

3. The interventionist uses an “I” message when indicated.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
4. The interventionist uses a positive tone of voice when verbalizing “I” messages.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree

5. The interventionist attempts to share information regarding the effects of prenatal
substance use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
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6. The interventionist uses a supportive approach when attempting to share information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
7. The interventionist conveys awareness of the woman’s willingness to hear information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
8. The interventionist explains the effects that prenatal substance use can have on the
mother, baby, and child.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
9. The interventionist use a nonjudgmental approach when explaining the effects that
prenatal substance use can have on the mother, baby, and child.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
10. The interventionist advocates a goal of abstinence rather than reduction of drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
11. The interventionist uses a supportive tone of voice when advocating abstinence rather
than reduction of drug use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
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12. The interventionist provides openings for the woman to react as information is
shared.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
13. The interventionist provides feedback.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
14. The interventionist uses a supportive tone of voice when providing feedback.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
15. The interventionist refers medical questions appropriately to the physician or nurse.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
16. The interventionist acknowledges the woman’s decision to discuss her drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
17. The interventionist verbalizes praise when acknowledging the woman’s decision to
discuss her drug use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
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18. The interventionist offers indicated referrals to the woman.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
19. The interventionist respectfully offers indicated referrals to the woman.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
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Appendix E
IAC TREATMENT FIDELITY INSTRUMENT – Draft 3
Interviewer: ________________ Patient: __________________ Rater: ______________
1. The interventionist uses a bridging comment when indicated to move the conversation
from interview to pre-treatment.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
3. The interventionist uses an “I” message when indicated.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
4. The interventionist uses a positive tone of voice when verbalizing “I” messages.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
5. The interventionist attempts to share information regarding the effects of prenatal
substance use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
6. The interventionist uses a supportive approach when attempting to share information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
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7. The interventionist conveys awareness of the woman’s willingness to hear information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
8. The interventionist explains the effects that prenatal substance use can have on the
mother, baby, and child.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
9. The interventionist use a nonjudgmental approach when explaining the effects that
prenatal substance use can have on the mother, baby, and child.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
10. The interventionist advocates a goal of abstinence rather than reduction of drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
11. The interventionist uses a supportive tone of voice when advocating abstinence rather
than reduction of drug use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
12. The interventionist provides openings for the woman to react as information is
shared.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
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13. The interventionist responds to the woman’s reaction.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
14. The interventionist uses a supportive tone of voice when responding to the woman’s
reaction.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
15. The interventionist acknowledges the woman’s decision to discuss her drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
17. The interventionist offers indicated referrals to the woman.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
18. The interventionist respectfully offers indicated referrals to the woman.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
19. The interventionist refers medical questions asked by the woman to the physician or
nurse.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
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Appendix F
IAC TREATMENT FIDELITY INSTRUMENT – Final Version
Interviewer: ________________ Patient: ____________________ Rater: ____________
1. The interventionist uses a bridging comment when indicated to move the conversation
from interview to pre-treatment.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
2. The interventionist uses a positive tone of voice when verbalizing a bridging comment.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; no bridging comment was verbalized
3. The interventionist uses an “I” message to express concern when indicated.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
4. The interventionist uses a positive tone of voice when verbalizing “I” messages.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; no “I” message was verbalized
5. The interventionist attempts to share information regarding the effects of prenatal
substance use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree

133

6. The interventionist uses a supportive approach when attempting to share information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; the interventionist did not attempt to share this information.

7. The interventionist conveys awareness of the woman’s willingness to hear information
regarding the effects of prenatal substance use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree

8. The interventionist explains the effects that prenatal substance use can have on the
mother, baby, and child.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
9. The interventionist use a nonjudgmental approach when explaining the effects that
prenatal substance use can have on the mother, baby, and child.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; the interventionist did not explain the effects of prenatal substance
use.

10. The interventionist advocates a goal of abstinence rather than reduction of drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
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11. The interventionist uses a supportive tone of voice when advocating abstinence rather
than reduction of drug use.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; a goal of abstinence was not advocated

12. The interventionist provides openings for the woman to react as information is
shared.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
13. The interventionist responds to the woman’s reaction.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
14. The interventionist uses a supportive tone of voice when responding to the woman’s
reaction.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; the interventionist did not respond to the women’s reaction

15. The interventionist acknowledges the woman’s decision to discuss her drug use.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
16. The interventionist offers indicated referrals to the woman.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
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17. The interventionist respectfully offers indicated referrals to the woman.
COMPETENCE

1 ------------------- 2 ------------------- 3 ------------------- 4 ------------------- 5
Strongly Disagree Disagree
Undecided
Agree
Strongly Agree
☐ Not applicable; no referrals were offered to the woman

18. The interventionist refers medical questions asked by the woman to the physician or
nurse.
ADHERENCE

1 ------------------- 2 ------------------- 3
Disagree
Undecided
Agree
☐ Not applicable; interventionist is a physician or nurse.
☐ Not applicable; no medical questions were asked by the woman
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Appendix G
Standardized Patient Identities
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
Obstetric hx
Medical hx

Substance use
history

Response to
interviewer

Nutrition
General
demeanor
Housing
Environment
Physical Needs
Support System
Vocation
Name
DOB - Age
G/P
GPTAL
LMP
EDD

Standardized Patient - 1
Emma Abbott
September 3, 1971 – 38 years
3/0
3–0–0–2-0
March 28, 2010
January 1, 2010
You are no longer involved with the father of your baby
You had two therapeutic abortions in your twenties.
Allergic to tetracycline - reaction is hives and difficulty breathing.
You have had irritable bowel syndrome for several years with
abdominal pain, bloating, and gas. You take hyoscyamine one tablet
(0.125 mg) every 4 hours as needed for cramping
You have a long history of alcohol use and you continue to drink
every day, including hard liquor. You do not like to be preached to
about drinking because your mom drank when she was pregnant
with you and you turned out ok.
Alcohol: 2 or 3 drinks/day – you have continued since learning you
were pregnant
Tobacco: you quit smoking 10 years ago
Drugs: no drug use
IAC Intervention: You are resistant to the IAC and become angry
when the interviewer tells you about the consequences of prenatal
alcohol exposure.
Referrals: You refuse all referrals and you are insulted that the
interviewer is suggesting that you need help.
You eat a balanced diet overall
You are resistant to any criticism of your alcohol intake and you
communicate this to the interviewer in no uncertain terms.
You rent a house in Templeton and live alone
You have MediCal coverage for your pregnancy
You have good support from family and friends in the area
You have a part-time job working in a feed store in Templeton
Standardized Patient - 2
Cathy Silverman
October 19, 1987 – 22 years
5/1
2–1–0–2-2
January 11, 2010
October 18, 2010
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Partner status

Obstetric hx

Medical hx
Substance use
history

Response to
interviewer

Nutrition
General
demeanor
Housing
Environment

You are not involved with the father of this baby (who is also the
father of your other children) and he is unaware of this pregnancy. He
was physically and verbally abusive to you and your daughters and
you left him and the relationship before you discovered you were
expecting. You do not want him to know where you are.
You had a therapeutic abortion in 2003 and a miscarriage the next
year. You have two-year-old twin daughters, Jill and Jamie. They
were born in 2008 by C/S at 35 weeks gestation and stayed in the
NICU for 10 days. You considered terminating this pregnancy for
some time but you have decided to keep the baby.
NKA – no significant history
You have a history of substance use. You are currently smoking 10
cigarettes daily. You smoke marijuana and use methamphetamines
and now that you have decided to keep the baby you have also
decided that you will not use drugs and will cut down on your
smoking. You are not initially truthful about this when the interviewer
asks you.
Alcohol: you rarely drank before learning of your pregnancy and none
since
Tobacco: 1 pack/day for 4 years. 10/day since learning you were
pregnant
Marijuana: 1/day for several years. You tell the interviewer that you
quit when you learned you were pregnant although this is not true as
you continue to smoke it once or twice a week.
Methamphetamine: 4 or 5 times/week for 2 years. You tell the
interviewer that you quit when you learned you were pregnant
although this is not true, as you have used it several times since you
learned of your pregnancy.
IAC Intervention: You accept the IAC intervention. When the
interviewer shows you a picture of a baby exposed to
methamphetamine, you look away and are visibly upset.
Subsequently, you will admit to your use when/if the interviewer asks
you about this
Referrals: You will accept all offered referrals and state that you are
through using and will try to quit smoking.
You try to make sure that you and your girls are we eat a balanced
diet. You have WIC, as well as food stamps and welfare
You are pleasant, well groomed, and polite.
You moved to this are from Southern California in February to escape
an abusive relationship. You discovered you were pregnant after you
arrived on the central coast. You are staying at the homeless center
and you are working on getting housing.
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Physical Needs You have MediCal coverage, welfare, food stamps and WIC
Support System You do not have any real social support. Your parents were divorced
when you were young. Your father remarried and you have not had
much contact with him in recent years. Your mother lives in Los
Angeles and you talk to her on the phone from time to time. She has
physical health issues and is also having a hard time making ends
meet. You are trying to be a good mother to your two daughters and
are good about seeking any assistance for which you are eligible.
Vocation
Unemployed
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
Obstetric hx

Standardized Patient - 3
Samantha Carey
September 24, 1983 – 26 years
1/0
1 –0– 0 – 0 - 0
April 1, 2010
January 5. 2011
You do not live with the father of your baby, James, but he is very
involved and supportive.
1st pregnancy.

Medical hx
Substance use
history

No significant medical hx – No known allergies
You like to drink beer and have had a few beers since you became
pregnant. You read somewhere that it is okay to have a glass of beer
now and then when pregnant.
Candid about use and did not think this was a problem.

Response to
Interviewer

Alcohol: 1 or 2 beers/day for 3 years – 2 or 3 beers/wk since aware of
pregnancy
Tobacco: you have never smoked
Drugs: none
IAC Intervention: You accept the intervention and are shocked when
you learn about the effects of prenatal alcohol use.
Referrals: you do not accept any referrals, as you do not think you
need any help.
You do not exercise and drink 3 to 4 sodas per day, down from 5 or 6.
You are attempting to reduce your fast food intake. You have
maintained your weight at 220 for the last 3 weeks. You are
concerned that your baby will not get enough nutrition if you are not
gaining weight.
This pregnancy is unplanned but wanted. You smile frequently during
visit and are open and candid.
You currently live with your grandmother in Arroyo Grande

Nutrition

General
demeanor
Housing
Environment
Physical Needs

You have a WIC appointment. Your friends are giving you a baby
shower next month.
Support System Father of baby is supportive and employed in Arroyo Grande. You
have a couple of close girlfriends and rely on them for emotional
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Vocation

Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
Obstetric hx

Medical hx
Substance use
history

Response to
interviewer

Nutrition

support.
You are on disability after being injured on the job as a stocker at
Wal-Mart. You receive $875/mo from state disability.
Standardized Patient - 4
Grace Downs
March 11, 1977 – 33 years
3/2
1 –0– 2 – 0 - 2
February 11, 2010
November 18, 2011
You are currently with your boyfriend Ronald Cole. He is not the
father of any of your children. You met him at the homeless shelter
when you were two months pregnant.
You have two older children, 13 and 11, born 10/15/96 and 5/10/99.
You had no problem during pregnancy or delivery and both were
born vaginally at term. They were removed from your care after
Child Welfare Services became involved six years ago and you have
had only occasional contact with them since.
Allergic to tegretol (rash) and have a history of mental health
disorders (bipolar, depression) and have been taking Zoloft (50 mg
qd) and lithium (slow release 450 mg bid) for some time.
You have smoked marijuana for several years and continue during
pregnancy and, although you have tried to stop the use of other drugs,
you have had several relapses on oxycontin and methamphetamine.
You are currently enrolled in POEG (Perinatal Outpatient Extended
Group is a community-based perinatal substance use treatment
program) in the south county and are at risk of being terminated from
the program due to “dirty” drug tests.
Alcohol: you drink a beer once in awhile but have not had any since
you became pregnant
Tobacco: you have not smoked for years
Drugs: Marijuana daily for several years – you continue to smoke
marijuana daily during pregnancy
Oxycontin and methamphetamine 2 or 3/wk when you could get it –
you have used both a few times since becoming aware of pregnancy
IAC Intervention: You accept the intervention and act shocked when
you hear about the effects of drug use (although you already have
heard this information before)
Referrals: you will accept any offered referrals and will promise to
follow through
You are have not gained much weight with your pregnancy and were
underweight to begin with. You have noticed that you have been
hungrier of late. You eat irregularly and your meals are obtained
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General
demeanor
Housing
Environment
Physical Needs
Support System
Vocation
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
Obstetric hx
Medical hx

Substance use
history

Response to
interviewer

through various services such as People’s Kitchen and churches. You
no longer are able to receive services through the community health
center “Healthcare for the Homeless Program” due to noncompliance
with meds, appointments and frequent outbursts and rages at the
staff.
You present well and are neat and clean. You minimize your drug
use and its consequences. You can be very manipulative and
charming and are very experienced with service agencies.
You are living with your boyfriend in section 8 housing
(government-subsidized program that allows lower income families
the opportunity to rent decent, safe and adequate housing that may
not be available to them otherwise).
You are hooked up with WIC and are receiving food stamps and
welfare payment support.
Boyfriend – you are estranged from your parents and siblings.
Unemployed
Standardized Patient - 5
Yvonne Castro
October 10, 1980 – 29 years
1/0
1 –0– 0 – 0 - 0
March 20, 2010
December 24, 2010
You are married but separated from your husband. Your boyfriend,
Victorio, is the father your baby. He is an illegal immigrant from
Mexico.
First pregnancy
No known allergies. You have high blood pressure and had been
taking 25 mg of atenolol daily, but quit when you found out you were
pregnant. You have been monitoring your blood pressure daily and it
was 110/70 today. Your OB/GYN is aware that you are not taking
your medication. You have a history of depression and anxiety that
continues through your pregnancy, though the frequency and severity
have decreased. You occasionally have panic attacks when you feel
you must escape. You had been taking Celexa but quit when you
found out you were pregnant.
You have been a heavy methamphetamine and alcohol user in the past
but you cut down a lot when you found out you were pregnant and
have been completely clean for the past 2 weeks. You have gone to a
couple of Narcotics Anonymous meetings. You do not feel that you
need any help to stay sober and clean at this time.
Alcohol: 2 or 3 glasses wine or mixed drinks daily – 2 or 3 /wk since
you became pregnant and none recently
Tobacco: you do not smoke
Drugs: methamphetamine daily at times for the last few years– you
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have used both a few times since becoming aware of pregnancy but
not in the last 2 weeks.
IAC Intervention: You accept the intervention and become tearful and
depressed when you hear about the effects of alcohol and drug use.
Referrals: you refuse offered referrals and feel you are on the right
track and do not need any help to stay clean.
Nutrition
You love to eat junk food and have 3 Snickers and a soda daily. You
listen to information but laugh and say that you understand the
interviewer is trying to help but, in all honesty, you love your junk
food too much to quit.
General
You are very polite to the interviewer but have been known to get
demeanor
angry and yell at others. You are a young woman who masks her
insecurity and desire for love with a tough, yet funny persona.
Housing
You are living with your aunt right now. She is supporting you but
Environment
you have to sleep on her couch, as there is not a bed for you.
Physical Needs You have MediCal.
Support System You grew up in an abusive and drug-using home. When your mom
abandoned you at age 12, you lived with your grandmother who uses
drugs as well. Your boyfriend is possessive, mistrustful and abusive.
Vocation
Unemployed
Standardized Patient - 6
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status

Obstetric hx
Medical hx

Substance use
history

Helen Parker
October 10, 1974 – 35 years
1/0
1 –0– 0 – 0 - 0
February 12, 2010
November 19, 2010
You think that Ken Jenkins is most likely the father your baby. He is
homeless, jobless, and lives in his car. He is 44 years old and
questions paternity. You are not actually sure who the father is but
none of the potential fathers can be relied upon for support.
First pregnancy
No known allergies. You have a history of herpes simplex virus II,
human papilloma virus, and cervical cancer, high blood pressure and
had been taking 25 mg of atenolol daily, but quit when you found out
you were pregnant. You have a history of severe endometriosis and
have been taking Percocet twice a day. You also have a history of
depression and a suicide attempt. You were prescribed Zoloft but are
not taking it for fears of the effects on your baby.
You have a history of drug use and have used methadone, cocaine,
methamphetamine, and marijuana. Your last “heavy” drug use was
2008/2009. You were in rehab in Santa Barbara in 2009 but left
because you could not afford the costs, which were $600/month. You
have been nauseous occasionally and have been using marijuana now
and then to help with this.
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Alcohol: 2 or 3 drinks month – none since you became pregnant
Tobacco: you do not smoke
Drugs: marijuana daily– you have continued to use a few times/week
since becoming aware of pregnancy
Response to
interviewer

IAC Intervention: You accept the intervention and are surprised and a
little skeptical to hear that prenatal marijuana use can affect your
baby.
Referrals: You are not interested receiving drug & alcohol services
and really don’t want to hear about them. You do not feel that you
need any help to stay sober and clean at this time.
Nutrition
You are trying to eat healthy, take vitamins, and avoid hard drugs.
General
Your affect is flat and you tell your story with a matter-of-fact tone.
demeanor
You are stubborn and don’t like to hear advice that contradicts what
you believe and want for yourself, but you are not outwardly rude.
You are depressed and insecure. You are not happy about being
pregnant but you are dealing with it the best way you know how. You
did not think you could get pregnant because of your severe
endometriosis.
Housing
You are living with a friend and sleeping on a couch in the living
Environment
room. Your friend will only let you live there temporarily until other
living arrangements can be made. Your social worker gave you a list
of housing resources but you have not called any of them.
Physical Needs You went to ALPHA Pregnancy Counseling & Support (a nonprofit
organization) for maternity clothes. You are applying for MediCal but
have not filed all of the necessary paperwork to receive your benefits
at this time.
Support System Your mom is trying to help you but is unhappy with your life choices.
Now she is trying to be a parent, when she should have been setting
limits 10 years ago. You feel resentful towards her but have no one
else who is supportive of you.
Vocation
Unemployed
Standardized Patient - 7
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
\
Obstetric hx
Medical hx

Sara Deming
April 30, 1974 – 36 years
1/0
1 –0– 0 – 0 - 0
January 25, 2010
November 1, 2010
You have been married to Tom Deming for 6 years. This is your
second marriage. Tom’s 10 year-old son from a previous marriage
lives with his ex-wife.
First pregnancy
No known allergies. You were in a serious motor vehicle accident
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Substance use
history

Response to
interviewer

Nutrition
General
demeanor

Housing
Environment
Physical Needs

(MVA) at age 32 and spent a month in the hospital recovering from
various injuries. You have been unable to return to your work as a
medical secretary as sitting in front of a computer screen for any
prolonged length of time produces neck pain.
Your doctors have prescribed a variety of medications to help you
deal with post-MVA sequelae. These include narcotic pain
medications (Oxycontin Percocet, Darvocet, and Vicodin) and antianxiety medications (Valium and Xanax). You have been using these
drugs for the last few years to battle depression and loneliness and
have continued to use them after learning of your pregnancy. You
have tried to stop on your own but have been unable to do so. Your
husband is unaware of the extent of your use and does not know that
you are continuing to take medications since you became pregnant.
The general practitioner (GP) who has been prescribing these drugs
does not know that you are pregnant.
Alcohol: none
Tobacco: none
Opiates/Valium: daily for three years – 3-4/wk since pregnant
IAC intervention: You will accept the IAC and when the interviewer
describes the consequences of prenatal opiate use and shows you
photos of infants who have been Oxycontin-exposed, you are tearful
and ashamed.
Referrals: If offered referrals, you tentatively accept them. You
realize that you might need help.
You have been trying to eat better since you learned you were
pregnant.
You are very reluctant to disclose your drug use since becoming
pregnant and are evasive and obviously ill at ease when asked about
this. When you do finally acknowledge that you have been using, you
are remorseful but do not fully seem to understand your
responsibility.
You live in an apartment in Atascadero with your husband.

Your husband is employed as an accounting clerk and is going to
school to become a CPA. He will graduate right after the baby is born
and has been offered a well-paying job in the agency in which he
works. Money is somewhat tight but you are managing - the
apartment in which you live is owned by your mother and your rent is
quite low. You qualify for MediCal and WIC.
Support System This was a planned pregnancy. Your husband wanted a large family
and both sets of parents really want grandchildren. You hoped that
becoming pregnant would help you get your act together and make
you feel happier. Your husband is very excited about the baby who is
a boy.
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Vocation
Name
DOB - Age
G/P
GPTAL
LMP
EDD
Partner status
Obstetric hx
Medical hx
Substance use
history

Response to
interviewer

Nutrition

Unemployed
Standardized Patient - 8
Jennifer Hansen
February 3, 1988 – 22 years
2/0
2–0–0–1-0
March 10, 2010
December 14, 2010
Father of baby, Rodney, is supportive
This was an unplanned pregnancy. You had a therapeutic abortion last
year.
NKA
You were taking approximately 160 mg of Oxycontin w/o a
prescription up until a month ago. Since then, you have been taking 20
mg of methadone (off the street) in an attempt to get off the
Oxycontin. You have not had any methadone for the last 4 days.
Alcohol: you drink alcohol very rarely and have not had anything to
drink since learning of your pregnancy
Tobacco: 15 cigarettes daily for 5 years – you have cut down to 7
cigarettes per day currently.
IAC Intervention: You accept the IAC intervention and become very
quiet when the interviewer discusses the consequences of prenatal use
Referrals: You accept referrals to a drug and alcohol counselor and a
public health nurse. You do not accept a referral to smoking cessation
but do accept pamphlets.
You are thin and undernourished. You have not gained any weight
since becoming pregnant. You want to have a healthy baby but you are
afraid because of your drug use.
You are distracted, impatient, agitated and tired.

General
demeanor
Housing
You are living with your boyfriend in a garage/apartment at your
Environment
father’s house.
Physical Needs You have MediCal coverage. Your boyfriend is working at a local
grocery store and earns enough to cover your expenses.
Support
Your parents are divorced. Your father is a recovering alcoholic and
System
heroin addict who has been clean for 13 years. Your mother is a
prescription drug addict. You do not feel close to either of your
parents.
Vocation
Unemployed
Name
DOB - Age
G/P
GPTAL

Standardized Patient - 9
Angela Meister
February 5, 1973 – 37 years
5/3
5–1–2–1-3
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LMP
EDD
Partner status

Obstetric hx

Medical hx
Substance use
history

Response to
interviewer

February 7, 2010
November 24, 2010
You divorced the father of your children in 2005; you share custody
of the children. You have lived with Danny Harris, the father of this
baby, for two years – he is a committed partner. This is his 1st child
and he is excited.
This is your 5th pregnancy; it was unplanned. All your deliveries have
been vaginal
1995: girl – full term – 8 lbs - no complications
1997: girl – full term – 7 lb 9 oz – no complications
1998: Miscarriage at 8 weeks followed by D&C
2000: boy - 37 weeks – 6 lb 3 oz - was induced early due to problems
with high blood pressure
No significant medical hx – No known allergies
Started smoking after divorce but quit when you found out about this
pregnancy.
Drinks a glass of wine once in awhile and you have never used other
drugs. You did not think that an occasional glass of wine was a
problem.
Alcohol: 1 glass of wine two or three times a week – this has
continued since learning of pregnancy.
Tobacco: ½ pack daily for five years – quit when learning of
pregnancy
Drugs: none
IAC Intervention: You accept the IAC intervention and become upset
when the interviewer discusses the consequences of prenatal alcohol
use. You do not really believe what she is telling you as you drank
moderately with your other children and they turned out fine.

Referrals: You do not accept any referrals as you do not think you
need it.
Nutrition
You eat well and have gained an appropriate amount of weight since
becoming pregnant. You like to cook and eat a balanced diet.
General
Happy about this pregnancy and your children are excited about
demeanor
having a little brother or sister.
Housing
You and your children are living with Danny in a large four-bedroom
Environment
home in a nice neighborhood that he owns. He has a business as a
house painter and makes a decent living.
Physical Needs You have MediCal coverage for your pregnancy
Support System You have several good friends and you are close to your sister who
lives nearby.
Vocation
You clean houses on a part-time. You like this as it gives you
flexibility and allows you to be home with your children.
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Appendix H
Rater Training Agenda


Study Background



Confidentiality Agreement



Consequences of Prenatal Substance Exposure



Screening and Assessment for Prenatal Use of Alcohol, Tobacco, and Other
Drugs



Motivational Interviewing



“I Am Concerned” (IAC) Brief Opportunistic Intervention
o IAC DVD
o IAC Treatment Manual Distribution
o Implementing the IAC



IAC Treatment Fidelity Instrument



IAC Treatment Fidelity Rating Practice



Rating Practice Review



Weekly Meeting Schedule



Distribution of Initial Audio Recording CDs and Fidelity Instruments
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Appendix I
Participant Preparation Meeting Agenda


Introductions



Study Background



IAC Implementation Review



Prenatal Intake Interview Form Adaptation



Pseudonym Selection



Intervention Practice



Demographic Information



Informed Consent



Simulated Clinic Schedule



Audio Recording Process



Tour of Clinic Locations
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Appendix J
Prenatal Intake Interview Form
NAME:

BIRTH DATE: ___ / ___ / ___

RACE:

MARITAL STATUS:

OCCUPATION:  HOMEMAKER

 STUDENT

AGE:

S M W D SEP

 OUTSIDE WORK

TYPE OF WORK:

EDUCATION (LAST GRADE COMPLETED):

HUSBAND/FATHER OF BABY:
LMP

___ / ___ / ___  DEFINITE

TOTAL
PREG

FULL
TERM

PREMATURE

 APPROXIMATE

AB INDUCED

 UNKNOWN

AB SPONT

EDD ___ / ___ / ___

ECTOPIC

MULT BIRTHS

LIVING

PAST PREGNANCIES
Date

GA
Wks

Length of
Labor

Birth
Weight

Sex
M/F

Type
Delivery

Anes

Place of
Delivery

PT Labor
Yes/No

Comments/
Complications

PAST MEDICAL HISTORY
0 Neg
+ Pos

DETAILS

O Neg
+ Pos

1. DIABETES

16. D (Rh) SENSITIZED

2. HYPERTENSION

17. PULMONARY (TB, ASTHMA)

3. HEART DISEASE

18. ALLERGIES (DRUGS)

4. AUTOIMM DISORDER

19. BREAST

5. KIDNEY DIS/ UTI

20. GYN SURGERY

6. NEURO/EPILEPSY

21. OPERATION/HOSPITALIZATION

7. PSYCHIATRIC

22. ANESTHETIC COMPLICATIONS

8. HEPATITIS/LIVER DIS

23. HISTORY OF ABNORMAL PAP

9. VARICOS/PHLEBITIS

24. UTERINE ANOMALIES/DES

10. THYROID DYS

25. INFERTILITY

11. TRAUMA/DOM VIOL

26. RELEVANT FAMILY HX

12. HX BLOOD TRANS

27. OTHER

COMMENTS:
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DETAIL S

GENETIC SCREENING/TERATOLOGY COUNSELING
INCLUDES PATIENT, BABY’S FATHER, OR ANYONE IN EITHER FAMILY
YES

NO

YES

PATIENT’S AGE  35 YEARS

CYSTIC FIBROSIS

THALESSEMIA

HUNTINGTON CHOREA

NEURAL TUBE DEFECT

MENTAL RETARDATION/AUTISM

CONGENITAL HEART DEFECT

NO

IF YES, TESTED FOR FRAGILE X?

DOWN SYNDROME

OTHER GENETIC/CHROM DISORDER

TAY-SACHS

MATERNAL METABOLIC DISORDER

SICKLE CELL DISEASE/TRAIT

PT OR FOB HAD CHILD WITH
BIRTH DEFECT NOT LISTED ABOVE?

HEMOPHILIA

RECURRENT PREGNANCY LOSS, OR STILLBIRTH

MUSCULAR DYSTROPHY

ANY OTHER

COMMENTS/COUNSELING: _________________________________________________________________________________________
___________________________________________________________________________________________________________________

INFECTION HISTORY

YES

NO

YES

HIGH RISK HEPATITS B/IMMUNIZED?

RASH/VIRAL ILLNESS SINCE LMP

EXPOSED TO TB

HISTORY OF STI, GC, HPV, SYPHILIS

PT/PARTNER HX GENTIAL HERPES

OTHER (SEE COMMENTS)

NO

COMMENTS/: ____________________________________________________________________________________________________ __
___________________________________________________________________________________________________________________

NUTRITION
Number of times per day usually eats?
1 2 3 4 5 6 7 more often

Planning to breastfeed?
 No
 combine with formula  not sure  Yes
Knowledge or experience with breastfeeding?
 none  observed friends/family  took class
 personal experience? Circle and comment:
negative
positive

Daily liquid intake (# of cups/glasses/cans):
water ____ juice ____ milk ____
decaffeinated coffee/tea ____
regular coffee/tea ____
regular soda/punch ____ decaf soda ____
Allergic to foods?
 Yes, describe:

 No

Any foods or food groups avoided?
(such as dairy, meat, etc)
 Yes, list which foods and note reason:

 No

Ever eat raw eggs/fish/meat, soft cheeses,  No
canned tuna or fish caught by friends or family?
 Yes, describe:
Food or non-food cravings?
(examples of non-foods are ice, plaster,
cornstarch, dirt, clay, laundry starch)
 Yes, describe:

 No

Currently taking prenatal vitamins?
 No, needs vitamins:

 Yes

Currently taking (if yes; type, amount, frequency):  None
In addition to prenatal vitamins:
 over-the-counter drugs:
 prescription medications:
 dietary supplements:
 home remedies:
 other:
Already enrolled in WIC?
 WIC site: _________________
 No, needs referral
Ever run out of food?
 Yes, describe
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 Yes
 No

Current discomforts?
 nausea
 vomiting
 edema
 diarrhea
 heartburn
 constipation

 No
 other

Have access to a working kitchen?
 No. Way to cook food? Comment:

 Yes

Physically active at least 3 times each week?
 Yes, comment:
 No, comment:
Pre-pregnancy weight: _____ lb Height: _____ Today’s
weight _____ lb
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Appendix K
Participant Recruitment Letter

Dear Care Provider,
I am conducting a research study for my dissertation. The research is to develop a tool
that will measure implementation of the “I Am Concerned” (IAC) intervention that is
conducted when a pregnant woman screens positively for prenatal use of alcohol, tobacco
or illicit drugs. This study is an important first step towards future research to determine
how effective the IAC is in reducing women’s use of harmful substances.
I am looking for front office staff members (MA, LVN, RN), whose job duties have
included IAC implementation for at least 2 years, to participate in the study. Participants
will attend a half-day IAC refresher training session with me. The actual study portion is
estimated to last 2 days and will take place in a simulated clinic setting at Cuesta College.
Participants will be reimbursed for lost wages for work hours missed due to participation
in the study.
Please call or email me if you are interested in being a part of this research and I can tell
you more about the study and answer any questions you have.
I sincerely welcome your involvement in this worthwhile effort,
Antonia Torrey RN, MSN
Duquesne University School of Nursing
Phone: 805 769 6705
Email: torreya@duq.edu
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Appendix L
Participant Demographic Tool
What is your age in years as of your last birthday?
________________________
What is your gender? (Circle number.)
Female
Male
Transgender
What is your race?
Non-Hispanic White
Non-Hispanic Black
Hispanic/Latino
Asian & Pacific Islander
American Indian & Alaska Native
Other
What is your present position?
_____________________________________
What is the total number of years you have worked in a prenatal clinic or office?
________________________
What is the total number of years you have implemented the “I Am Concerned”
intervention?
_________________________________What is your highest level of education?
High School
Diploma
Associate degree
Bachelor’s degree in____________
Master’s degree in _____________
Doctorate in ______________
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Appendix M
DUQUESNE UNIVERSITY
600 FORBES AVENUE  PITTSBURGH, PA 15282
CONSENT TO PARTICIPATE IN A RESEARCH STUDY
TITLE:

INVESTIGATOR/ADVISOR

Development and Psychometric Evaluation of a
Structured Instrument to Assess the Treatment
Fidelity of a Brief Opportunistic Intervention
Designed to Reduce Substance Use Among
Pregnant Women
Linda Goodfellow PhD, RN
Associate Professor
Duquesne University School of Nursing
School of Nursing
517 Fisher Hall
Pittsburgh, PA 15282
412-396-6548

STUDENT CO-INVESTIGATOR: Antonia Torrey, RN, MSN
8315 Portola Road
Atascadero, CA 93422
SOURCE OF SUPPORT:

This study is being performed as partial fulfillment
of the requirements for the Doctor of Philosophy in
Nursing at Duquesne University

PURPOSE:

You are being asked to participate in a research
project to investigate the usefulness of a research
instrument that measures the faithfulness with
which an intervention, designed to reduce prenatal
use of alcohol, tobacco and other drugs, is
performed. If you decide to participate in this
research, you will conduct prenatal interviews in a
simulated prenatal clinic setting with nursing
students portraying pregnant women. You will
follow the process that you use when performing
your job duties in the prenatal clinic or office in
which you work, including substance use screening
and conducting the “I Am Concerned” brief
opportunistic intervention. Interviews will be audio
recorded and these recordings will be used during
the study to evaluate the quality of the research
instrument referred to above.

RISKS AND BENEFITS:

There are no known risks greater than everyday
activities or direct benefits from participating in this
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study. However, you will have the knowledge that
you will help the researchers examine the
usefulness of a research instrument that measures
the faithfulness with which an intervention,
designed to reduce prenatal use of alcohol, tobacco
and other drugs, is performed. An indirect benefit
is the potential reduction in fetal substances
exposure through dissemination of these study
findings to a larger health care audience.
COMPENSATION:

You will be compensated at approximately your
normal hourly rate (MA/$12, LVN/$15, RN/$20)
for wages lost as a result of work hours missed
while directly participating in this study.

CONFIDENTIALITY:

Your name will never appear on any survey or
research instruments. Your identity will not be
revealed in the data analysis. All written materials,
audiotapes, and consent forms will be stored in a
locked file cabinet in the researcher's office. The
consent forms will be kept separate from the other
research materials. All materials will be destroyed
at the completion of the research.

RIGHT TO WITHDRAW:

You are under no obligation to participate in this
study. You are free to withdraw your consent to
participate at any time.

SUMMARY OF RESULTS:

A summary of the results of this research will be
supplied to you, at no cost, upon request.

VOLUNTARY CONSENT:

I have read the above statements and understand
what is being requested of me. I also understand
that my participation is voluntary and that I am free
to withdraw my consent at any time, for any reason.
On these terms, I certify that I am willing to
participate in this research project. I understand that
should I have any further questions about my
participation in this study, I may call the Principle
Investigator and Advisor, Dr. Linda Goodfellow,
412-396-6548, the Student Co-Investigator, Antonia
Torrey at 805-769-6705, or Dr. Paul Richer, Chair
of the Duquesne University Institutional Review
Board at (412) 396-6326.

_________________________________________
Participant's Signature

__________________
Date

_________________________________________
Researcher Signature

__________________
Date
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Appendix N
Rater Confidentiality Statement

I, _______________________________________, the Research Assistant/Rater, agree
to:
1. Keep all research information shared with me confidential by not discussing or
sharing research information in any form or format (audio recordings, fidelity
measurement instruments) with anyone other than the Researcher or a member of the
research team.
2. Keep all research information in any form or format (audio recordings, fidelity
measurement instruments) secure while in my possession.
3. Return all research information in any form or format (audio recordings, fidelity
measurement instruments) to the Researcher when I have completed the research
tasks.
Research Assistant/Rater
__________________________
Print Name

_______________________
Signature

______________
Date

_______________________
Signature

______________
Date

Researcher
__________________________
Print Name
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